Viral pneumonia (unknown virus, not influenza)

VIRALPNEUMONAS

viral pneumonia: Inflammation of the lung parenchyma that is caused by a viral infection.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J12.8, J12.9 Hospital discharge: ICD-9 — 480 Hospital discharge: ICD-8 — 480 Hospital discharge: excluded ICD-9 — 480[0-2] Cause of death: ICD-10 — J12.8, J12.9 Cause of death: ICD-9 — 480 Cause of death: ICD-8 — 480 Cause of death: excluded ICD-9 — 480[0-2] 2 out of 7 registries used, show all original rules.	2932
4. Check minimum number of events None	2932
5. Include endpoints None	2932
6. Filter based on genotype QC (FinnGen only)	2757

Control definitions (FinnGen only)

Control exclude: ASTHMA_PNEUMONIA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	VIRALPNEUMONAS
CONTROL_EXCLUDE	ASTHMA_PNEUMONIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J128\|J129
HD_ICD_9	480
HD_ICD_8	480
HD_ICD_10_EXCL
HD_ICD_9_EXCL	480[0-2]
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J128\|J129
COD_ICD_9	480
COD_ICD_8	480
COD_ICD_10_EXCL
COD_ICD_9_EXCL	480[0-2]
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral pneumonia (unknown virus, not influenza) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22206	9354	12641
Only index persons	17921	7501	10420
Unadjusted period prevalence (%)
Whole population	0.32	0.27	0.35
Only index persons	0.35	0.28	0.40
Median age at first event (years)
Whole population	26.87	35.15	20.24
Only index persons	21.48	24.06	19.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2757	1292	1465
Unadjusted period prevalence (%)	0.57	0.46	0.67
Median age at first event (years)	55.85	51.90	59.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2930: Matched controls
29300

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

9.2

307.7

1671

3694

J18.9

ICD-10 Finland

Pneumonia, unspecified

5.0

307.7

1229

3693

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

1467.3

307.7

840

48099

ICD-8 Finland

Viral pneumonia

+∞

307.7

334

J12.8

ICD-10 Finland

Other viral pneumonia

4949.8

307.7

1434

4809X

ICD-9 Finland

Viral pneumonia, unspecified

+∞

276.5

261

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.5

170.9

737

2560

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.0

153.7

290

529

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

15.9

144.2

125

J45.9

ICD-10 Finland

Asthma, unspecified

3.1

128.4

647

2431

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.2

126.6

373

986

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.0

125.0

688

2714

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

122.9

1501

8753

L04AA06

ATC

mycophenolic acid; systemic

8.0

102.4

142

186

H02AB06

ATC

prednisolone; systemic

2.3

99.0

1491

9233

C03CA01

ATC

furosemide; systemic

2.4

98.8

914

4606

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

95.1

590

2449

J45.1

ICD-10 Finland

Nonallergic asthma

4.2

91.9

264

680

R06.0

ICD-10 Finland

Dyspnoea

2.4

90.7

872

4442

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.3

90.6

382

1274

R4110

NOMESCO Finland

Physiotherapy

2.3

89.4

930

4897

R03AC02

ATC

salbutamol; inhalant

2.2

88.9

1694

11341

TGC00

NOMESCO Finland

Bronchial lavation

6.7

87.2

142

222

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.6

85.6

307

923

R50.9

ICD-10 Finland

Fever, unspecified

2.6

85.3

586

2548

127

Kela drug reimbursment

Transplant complication

7.4

82.0

121

170

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

80.5

406

1499

R03BB04

ATC

tiotropium bromide; inhalant

3.3

80.3

334

1102

4808X

ICD-9 Finland

Viral pneumonia, Pneumonia due to other virus not elsewhere classified

+∞

79.5

Z29.8

ICD-10 Finland

Other specified prophylactic measures

5.0

77.3

171

357

GD1AD

NOMESCO Finland

Thorax CT examination

3.9

76.8

242

665

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

75.8

627

2959

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

14.5

75.1

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.4

74.3

283

882

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

6.4

74.3

125

202

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

72.7

728

3724

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.1

69.4

312

1075

L04AD02

ATC

tacrolimus; systemic

8.4

67.3

107

J45

ICD-10 Finland

Asthma

2.9

67.0

343

1271

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

67.0

540

2507

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

65.3

255

806

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.4

63.3

163

385

J01MA14

ATC

moxifloxacin; systemic

2.9

62.5

312

1139

I50.9

ICD-10 Finland

Heart failure, unspecified

2.6

61.9

416

1770

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

61.2

430

1868

J46

ICD-10 Finland

Status asthmaticus

6.1

59.8

105

177

R03BA02

ATC

budesonide; inhalant

2.3

59.5

549

2691

ZXE00

NOMESCO Finland

One hour or less

1.9

58.9

1166

7548

J01MA12

ATC

levofloxacin; systemic

2.2

58.7

570

2852

ZX108

NOMESCO Finland

Inhalation

12.3

58.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.8

56.7

131

283

R03DA04

ATC

theophylline; systemic, rectal

4.0

56.2

168

443

R02

ICPC

Shortness of breath/dyspnoea

2.4

55.1

412

1837

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

54.6

1518

10849

R03DC03

ATC

montelukast; oral

2.3

53.5

488

2371

R03AC03

ATC

terbutaline; inhalant

2.3

51.8

427

1986

R83

ICPC

Respiratory infection other

1.9

51.5

842

5073

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.8

50.9

284

1097

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

7.4

50.1

101

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.1

49.8

215

720

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.8

49.2

112

239

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

49.2

557

2941

ZX120

NOMESCO Finland

Intravenous

2.6

48.3

314

1308

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

47.9

1080

7163

R03BA05

ATC

fluticasone; inhalant

2.1

47.5

532

2794

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

47.5

1020

6666

WX730

NOMESCO Finland

Conventional respirator

6.4

47.1

127

Z2221

NOMESCO Finland

Medical doctor

1.9

47.1

811

4945

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.9

46.2

104

220

TK800

NOMESCO Finland

Hemodialysis

4.8

45.9

105

225

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

45.7

163

485

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.5

45.4

304

1283

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

7.3

45.4

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

45.2

1536

11394

R03AK07

ATC

formoterol and budesonide; inhalant

2.0

45.2

602

3361

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

45.0

208

724

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.6

44.5

106

235

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

5.7

44.4

152

R81

ICPC

Pneumonia

4.0

44.1

129

335

R03AC12

ATC

salmeterol; inhalant

3.8

43.6

135

365

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.4

43.3

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.3

43.0

168

529

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

43.0

422

2101

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.7

42.9

141

397

J96.1

ICD-10 Finland

Chronic respiratory failure

5.4

42.8

161

Z3231

NOMESCO Finland

Registered nurse

1.8

42.6

797

4963

Z94.0

ICD-10 Finland

Kidney transplant status

6.1

41.9

122

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

41.7

830

5261

J45.8

ICD-10 Finland

Mixed asthma

4.5

41.5

103

236

N02AX02

ATC

tramadol; systemic, rectal

1.7

40.7

1181

8314

AA1AD

NOMESCO Finland

CT of head and brain

1.8

40.4

745

4608

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

40.2

346

1630

B34.2

ICD-10 Finland

Coronavirus infection, unspecified site

8.4

39.9

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.1

39.8

110

274

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

4.7

39.5

200

ZXD05

NOMESCO Finland

Urgent procedure

1.8

39.4

877

5727

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.0

39.4

177

606

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

39.0

749

4682

A02BC02

ATC

pantoprazole; systemic

1.7

38.9

1842

14678

R60.0

ICD-10 Finland

Localized oedema

2.2

38.8

348

1667

J01FA06

ATC

roxithromycin; oral

1.7

38.5

1068

7400

N03AX16

ATC

[U] pregabalin

1.9

38.3

637

3806

A46

ICD-10 Finland

Erysipelas

2.1

38.1

428

2237

H02AB04

ATC

methylprednisolone; systemic

2.1

37.9

395

2007

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

37.6

376

1879

Z29.0

ICD-10 Finland

Isolation

14.3

37.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.8

37.3

114

305

JN4AD

NOMESCO Finland

Body CT examination

2.3

37.2

298

1360

R53

ICD-10 Finland

Malaise and fatigue

1.8

37.1

688

4245

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.6

36.8

125

360

J96.0

ICD-10 Finland

Acute respiratory failure

6.2

36.6

104

XW000

NOMESCO Finland

Bone marrow biopsy

3.2

36.4

152

498

A41.9

ICD-10 Finland

Sepsis, unspecified

3.5

36.4

129

382

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.6

36.4

123

353

I50.0

ICD-10 Finland

Congestive heart failure

2.7

35.8

203

788

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

35.8

328

1583

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.9

35.6

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

35.6

197

755

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.8

35.3

188

706

L28

ICPC

Limited function/disability (L)

2.0

35.2

470

2608

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

34.8

768

4973

H02AB07

ATC

prednisone; oral

2.1

34.6

368

1880

A28

ICPC

Limited function/disability NOS

2.0

34.6

444

2428

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

34.5

282

1297

Z3226

NOMESCO Finland

Physiotherapist

1.9

34.2

518

2993

WX892

NOMESCO Finland

Monitored bed care

2.4

34.0

243

1054

B01AB05

ATC

enoxaparin; parenteral

1.7

34.0

812

5369

R05

ICPC

Cough

1.8

33.9

660

4117

N18.0

ICD-10 Finland

End-stage renal disease

6.5

33.7

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

33.6

208

843

C07AB07

ATC

bisoprolol; oral

1.6

33.5

1234

9102

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.3

33.4

128

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.0

33.4

157

551

J20

ICD-10 Finland

Acute bronchitis

2.2

33.0

294

1400

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

6.4

33.0

WX402

NOMESCO Finland

General anaesthesia

1.8

32.8

608

3735

J01AA02

ATC

doxycycline; systemic

1.7

32.5

2076

17423

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.6

32.4

202

821

J01FF01

ATC

clindamycin; systemic

1.7

31.9

748

4905

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

31.9

319

1591

V03AE02

ATC

sevelamer; oral

9.4

31.8

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.4

31.4

183

WX726

NOMESCO Finland

High-flow oxygen therapy

39.5

31.2

N18.8

ICD-10 Finland

Other chronic renal failure

3.8

31.2

254

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

31.1

119

370

WW200

NOMESCO Finland

Immunization

3.5

30.9

109

322

B03XA02

ATC

darbepoetin alfa; parenteral

3.9

30.8

238

J15.8

ICD-10 Finland

Other bacterial pneumonia

9.6

30.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

30.2

348

1827

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.5

30.2

164

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.7

30.1

260

Z71.8

ICD-10 Finland

Other specified counselling

1.6

30.0

861

5935

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

29.9

449

2580

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.7

28.7

J01CA04

ATC

amoxicillin; systemic

1.7

28.5

2335

20446

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

8.3

28.3

TK810

NOMESCO Finland

Hemofiltration

8.3

28.3

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.0

28.1

130

452

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.6

28.1

49300

ICD-8 Finland

Asthma, bronchiale

4.5

28.1

157

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

9.8

27.7

Z2446

NOMESCO Finland

Social worker

2.3

27.6

212

947

A03

ICPC

Fever

1.8

27.4

508

3104

J01DB01

ATC

cefalexin; oral

1.7

27.4

2322

20364

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

8.3

27.4

R03BB01

ATC

ipratropium bromide; inhalant

3.4

27.4

101

307

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

27.0

532

3306

A12AA04

ATC

calcium carbonate; oral

4.4

26.7

155

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

26.7

730

4948

A11CC03

ATC

alfacalcidol; systemic

3.5

26.7

263

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.3

26.5

160

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

7.2

26.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.5

26.2

141

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

25.9

104

333

E66.8

ICD-10 Finland

Other obesity

2.5

25.9

162

659

H02AB09

ATC

hydrocortisone; systemic

3.4

25.9

278

C08CA01

ATC

amlodipine; oral

1.6

25.7

932

6741

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.4

25.7

188

822

A10AB05

ATC

insulin aspart; parenteral

2.2

25.3

235

1135

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

25.3

184

803

R03AC13

ATC

formoterol; inhalant

2.7

25.3

134

502

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

25.2

967

7077

WW500

NOMESCO Finland

Blood transfusion

2.8

25.2

131

486

M04AA01

ATC

allopurinol; systemic

1.9

25.1

346

1926

J01MA02

ATC

ciprofloxacin; systemic

1.5

25.1

1008

7451

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

25.1

195

876

R03AK11

ATC

formoterol and fluticasone; inhalant

3.7

25.0

226

GD2SN

NOMESCO Finland

Lung ventilation SPECT

7.2

25.0

R03AK08

ATC

formoterol and beclometasone; inhalant

2.9

24.9

122

438

N02BE01

ATC

paracetamol; systemic, rectal

1.7

24.9

2452

21972

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

9.2

24.7

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

6.7

24.7

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

24.6

179

781

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

24.3

183

811

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

24.2

602

3971

G47.3

ICD-10 Finland

Sleep apnoea

1.6

24.2

621

4131

B01AB10

ATC

tinzaparin; parenteral

2.0

24.0

265

1367

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.5

23.8

R06AE07

ATC

cetirizine; oral

1.5

23.8

1154

8849

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

23.7

800

5675

WX002

NOMESCO Finland

Sedation and analgesia

1.7

23.7

497

3135

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

23.6

1982

16972

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

23.6

162

689

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

23.5

537

3462

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.4

23.5

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

23.5

171

746

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

23.4

626

4201

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.7

23.4

125

470

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

23.2

166

719

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

23.2

633

4270

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.1

23.0

156

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

22.9

249

1277

L04AX01

ATC

azathioprine; systemic

2.6

22.8

137

547

GD1UN

NOMESCO Finland

Lung circulation SPECT

7.5

22.5

R96

ICPC

Asthma

2.1

22.5

229

1146

A02BC01

ATC

omeprazole; systemic

1.6

22.2

675

4663

J01FA10

ATC

azithromycin; systemic

1.5

22.2

1559

12802

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.7

22.2

192

R03BA01

ATC

beclometasone; inhalant

1.8

22.1

333

1905

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.6

22.1

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

21.8

356

2086

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.7

21.7

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.2

21.6

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.6

21.4

589

3969

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

21.4

576

3864

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.8

21.4

174

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.7

21.3

188

A06AD11

ATC

lactulose; oral

1.8

21.3

366

2179

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

21.2

1123

8711

B01AF02

ATC

apixaban; oral

1.9

21.1

307

1736

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

21.0

1442

11739

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

21.0

311

S97

ICPC

Chronic ulcer skin

2.3

20.7

162

729

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.7

20.7

48609

ICD-8 Finland

Pneumonia, unspecified

4.2

20.6

134

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

20.5

248

1319

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

20.3

188

906

L04AD01

ATC

ciclosporin; systemic

3.5

20.3

199

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

20.3

298

1689

N30.0

ICD-10 Finland

Acute cystitis

1.7

20.3

383

2339

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.0

20.3

243

1289

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

20.0

663

4657

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

19.9

371

2258

137

Kela drug reimbursment

Uraemia requiring dialysis

4.8

19.9

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

19.8

184

889

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

19.6

960

7305

R4190

NOMESCO Finland

Nutritional therapy

2.6

19.5

115

455

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

19.5

263

1452

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

19.4

180

869

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

19.2

138

599

R51.80

ICD-10 Finland

Headache

1.7

19.1

412

2608

E0000UV, ,

ATC

1.4

18.9

1069

8344

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

8.1

18.8

A02BC05

ATC

esomeprazole; systemic

1.4

18.8

996

7681

WX110, ,

SPAT

2.1

18.7

182

894

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

18.6

1143

9054

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

18.4

1112

8777

SPAT1255

SPAT

Intravenous administration of medicine

2.1

18.2

178

876

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

3.0

18.2

271

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

18.1

137

608

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.6

18.1

166

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

18.1

599

4196

B01AB04

ATC

dalteparin; parenteral

2.3

18.0

138

616

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

18.0

324

1950

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

17.9

238

1307

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

16.6

17.8

ZXA00

NOMESCO Finland

Right side

1.5

17.8

632

4490

J01CF05

ATC

flucloxacillin; systemic

2.1

17.8

172

843

J01FA09

ATC

clarithromycin; systemic

1.5

17.7

774

5740

EB1AA, ,

SPAT

2.0

17.6

193

991

WX213

NOMESCO Finland

Lower leg blockade

5.4

17.6

R04.2

ICD-10 Finland

Haemoptysis

2.7

17.5

349

C03DA01

ATC

spironolactone; oral

1.8

17.5

279

1621

WX872

NOMESCO Finland

Intensive care

2.2

17.5

144

663

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.9

17.4

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.1

17.4

N02BF02

ATC

pregabalin; oral

2.2

17.4

155

737

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

17.3

123

531

A10AC01

ATC

insulin (human); parenteral

2.0

17.3

208

1103

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

17.3

131

582

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

4.6

17.3

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

17.2

311

1872

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

17.2

258

R11

ICD-10 Finland

Nausea and vomiting

1.9

17.2

230

1265

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

17.1

105

424

E87.5

ICD-10 Finland

Hyperkalaemia

3.7

17.0

149

N17.8

ICD-10 Finland

Other acute renal failure

4.2

17.0

109

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

17.0

256

1462

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

17.0

698

5106

J01DA06

ATC

[U] cefuroxime

1.7

16.9

353

2210

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

16.8

533

3690

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

16.8

311

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.7

16.8

146

B01AA03

ATC

warfarin; systemic

1.6

16.7

434

2870

V03AE01

ATC

polystyrene sulfonate; oral

4.0

16.5

120

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.0

16.5

120

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.2

16.5

107

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.0

16.5

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.1

16.4

228

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.1

16.4

C08CA02

ATC

felodipine; oral

1.9

16.4

223

1233

JN4BD

NOMESCO Finland

Extensive body CT

1.8

16.4

248

1418

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

16.3

185

963

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

16.2

267

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

6.5

16.2

N05BA01

ATC

diazepam; systemic, rectal

1.7

16.1

316

1946

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

16.0

243

1390

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.9

16.0

123

R05

ICD-10 Finland

Cough

1.5

15.9

514

3572

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.3

15.9

176

M10.9

ICD-10 Finland

Gout, unspecified

2.0

15.8

177

917

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

15.8

134

625

N05BA04

ATC

oxazepam; oral

1.5

15.8

633

4600

N19

ICD-10 Finland

Unspecified kidney failure

2.6

15.7

375

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

15.7

486

3346

J47

ICD-10 Finland

Bronchiectasis

3.8

15.6

121

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

6.2

15.5

B05DB

ATC

Hypertonic solutions

5.0

15.5

ZY010

NOMESCO Finland

Hospital outpatient

2.1

15.4

154

765

R03CC02

ATC

salbutamol; systemic

2.0

15.4

180

947

R03DC01

ATC

zafirlukast; oral

4.0

15.3

109

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

15.2

208

1153

N06AX11

ATC

mirtazapine; oral

1.4

15.1

834

6423

Z94.2

ICD-10 Finland

Lung transplant status

20.1

15.1

R42

ICD-10 Finland

Dizziness and giddiness

1.5

15.0

522

3680

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

6.5

14.9

R74

ICPC

Upper respiratory infection acute

1.4

14.8

827

6377

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

14.8

449

3072

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

14.8

238

1385

R03BC01

ATC

cromoglicic acid; inhalant

3.4

14.8

154

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

14.7

117

531

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.8

14.7

265

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.3

14.7

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

14.6

175

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

14.6

235

1367

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

14.6

266

1604

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

14.6

244

J128, U071,

ICD-10 Finland

+∞

14.6

J01FA01

ATC

erythromycin; systemic

1.6

14.6

353

2292

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.7

14.6

289

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

14.5

208

1168

J01DA01

ATC

[U] cefalexin

1.4

14.5

1592

13680

49099

ICD-8 Finland

Bronchitis, unspecified

4.5

14.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

14.5

119

548

ZXA05

NOMESCO Finland

Left side

1.5

14.4

571

4130

A10AE04

ATC

insulin glargine; parenteral

1.7

14.3

248

1474

GDG10

NOMESCO Finland

Bilateral transplantation of lung

27.3

14.3

WVA20

NOMESCO Finland

Medicine administration

2.6

14.2

304

KBV00

NOMESCO Finland

Insertion of stent into ureter

5.3

14.2

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

14.2

431

2950

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.2

14.1

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

14.0

195

1085

R52.9

ICD-10 Finland

Pain, unspecified

1.7

14.0

241

1429

Z49.2

ICD-10 Finland

Other dialysis

4.6

14.0

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

13.9

618

4564

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

13.9

759

5818

XG466

NOMESCO Finland

Sleep oxymetry

2.5

13.8

332

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.4

13.8

T90

ICPC

Diabetes non-insulin dependent

1.5

13.8

538

3877

SPAT1229

SPAT

Assessment of need for aid

1.9

13.7

174

941

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

13.6

231

H05BX01

ATC

cinacalcet; oral

5.1

13.6

ZXA10

NOMESCO Finland

Bilateral

1.5

13.6

422

2899

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

13.5

493

3502

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.5

13.5

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.1

13.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

13.4

332

2165

R33

ICD-10 Finland

Retention of urine

1.8

13.2

195

1105

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.6

13.2

121

L04AX04

ATC

lenalidomide; oral

5.3

13.2

N05CF01

ATC

zopiclone; oral

1.4

13.2

747

5755

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.5

13.2

131

WX723

NOMESCO Finland

CPAP therapy

2.2

13.2

113

530

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

13.1

124

605

UKC02

NOMESCO Finland

Cystoscopy

1.6

13.0

373

2518

M79.6

ICD-10 Finland

Pain in limb

1.4

13.0

1002

8113

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

13.0

258

1593

153

Kela drug reimbursment

Lenalidomid

5.2

13.0

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

12.9

109

508

Z01.7

ICD-10 Finland

Laboratory examination

1.6

12.9

364

2448

R03BA08

ATC

ciclesonide; inhalant

1.8

12.8

194

1108

207

Kela drug reimbursment

Chronic arrhythmias

1.6

12.8

334

2207

B34.9

ICD-10 Finland

Viral infection, unspecified

2.3

12.7

395

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

12.7

566

4177

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.7

12.6

241

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

12.6

100

454

L03AA02

ATC

filgrastim; parenteral

2.5

12.6

323

UJF32

NOMESCO Finland

Coloscopy

1.4

12.6

590

4392

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.5

12.6

X58

ICD-10 Finland

Exposure to other specified factors

1.5

12.6

377

2568

N05AH04

ATC

quetiapine; oral

1.5

12.6

451

3191

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

12.5

198

1147

B05DA

ATC

Isotonic solutions

4.2

12.5

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

6.2

12.5

R01AD09

ATC

mometasone; nasal

1.3

12.5

1115

9217

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

12.4

272

SPAT1262

SPAT

Handing over of treatment supplies

1.5

12.4

408

2836

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

12.3

135

694

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

12.3

837

6632

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

12.3

446

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

12.2

486

3507

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

12.2

334

A07AA02

ATC

nystatin; oral

2.0

12.2

126

634

A10AE05

ATC

insulin detemir; parenteral

1.9

12.2

143

753

J43.9

ICD-10 Finland

Emphysema, unspecified

3.4

12.2

123

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

12.2

340

2279

WX722

NOMESCO Finland

PEEP

2.1

12.2

116

567

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

12.1

137

712

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

12.1

175

986

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

12.1

175

986

ZXD20

NOMESCO Finland

Day surgery

1.6

12.1

300

1956

3025

Kela drug reimbursment

Calcium carbonate

6.0

12.1

N02AA05

ATC

oxycodone; systemic

1.5

12.1

390

2697

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

12.1

262

1653

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

4.1

12.1

R5110, ,

SPAT

1.9

12.0

147

785

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.1

12.0

165

I50.1

ICD-10 Finland

Left ventricular failure

2.1

12.0

113

550

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

12.0

165

916

A23

ICPC

Risk factor NOS

1.7

12.0

229

1399

A10BA02

ATC

metformin; oral

1.4

12.0

643

4900

R4120

NOMESCO Finland

Occupational therapy

1.9

11.9

163

904

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.7

11.9

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.0

11.8

177

R01AD08

ATC

fluticasone; nasal

1.4

11.8

688

5313

L04AA01

ATC

[U] ciclosporin

3.4

11.8

121

P01BA02

ATC

hydroxychloroquine; oral

1.8

11.8

177

1010

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.3

11.8

131

N03AX12

ATC

[U] gabapentin; oral

1.5

11.7

373

2574

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

11.7

443

329

Kela drug reimbursment

Lenalidomide

5.5

11.6

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

11.6

690

5344

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

11.6

126

647

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

11.5

204

1220

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.0

11.5

164

R06.2

ICD-10 Finland

Wheezing

2.1

11.5

107

519

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

11.4

351

2402

WZC30

NOMESCO Finland

Teaching

1.5

11.4

362

2496

R52.0

ICD-10 Finland

Acute pain

2.2

11.3

403

J02AC01

ATC

fluconazole; systemic

1.3

11.3

847

6797

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

11.3

114

570

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

11.3

539

4020

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

11.3

198

1182

C09AA05

ATC

ramipril; oral

1.4

11.2

550

4119

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

11.2

162

913

K07

ICPC

Swollen ankles/oedema

2.1

11.2

103

497

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

11.2

531

3954

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

3.6

11.2

101

N06AX16

ATC

venlafaxine; oral

1.5

11.2

339

2314

W19

ICD-10 Finland

Unspecified fall

1.6

11.1

241

1520

A41.8

ICD-10 Finland

Other specified sepsis

3.0

11.1

167

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

11.1

291

1921

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.3

11.1

126

H3603, E103,

ICD-10 Finland

3.5

11.0

107

A04

ICPC

Weakness/tiredness general

1.5

10.9

355

2457

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

10.9

358

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

10.9

300

2004

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

10.9

462

3371

M05BA04

ATC

alendronic acid; oral

1.8

10.8

164

938

C90.0

ICD-10 Finland

Multiple myeloma

3.5

10.8

108

S76

ICPC

Skin infection other

1.9

10.8

129

685

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.8

10.8

198

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

10.8

126

664

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

10.8

123

643

J80

ICD-10 Finland

Adult respiratory distress syndrome

8.9

10.7

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

1.9

10.7

140

765

S29

ICPC

Skin symptom/complaint other

1.4

10.7

437

3167

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

10.6

177

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

10.6

283

1876

J18.2

ICD-10 Finland

Hypostatic pneumonia, unspecified

60.2

10.6

R04.0

ICD-10 Finland

Epistaxis

1.7

10.6

175

1027

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.2

10.6

428

ZXD35

NOMESCO Finland

Usual procedure

2.3

10.6

370

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

10.5

206

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.3

10.5

358

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

10.5

172

1008

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

10.4

217

1355

AN1

Coronary angiography

1.6

10.4

236

1505

48009, ,

ICD-8 Finland

+∞

10.4

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

4.1

10.4

RS220, ,

NOMESCO Finland

3.2

10.4

126

R4180

NOMESCO Finland

Podiatric therapy

3.3

10.4

116

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.0

10.4

147

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

10.4

333

2299

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

10.4

133

723

N05CD07

ATC

temazepam; oral

1.6

10.3

246

1589

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

10.3

113

582

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

10.3

147

826

XF404

NOMESCO Finland

Ambulatory ECG

1.7

10.3

202

1243

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

10.3

130

703

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.5

10.3

102

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

10.3

234

1495

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

10.3

175

1036

M54.5

ICD-10 Finland

Low back pain

1.3

10.3

863

7023

L04AA13

ATC

[U] leflunomide

2.6

10.3

238

J05AB01

ATC

aciclovir; systemic

1.4

10.3

497

3710

Z94.1

ICD-10 Finland

Heart transplant status

10.6

10.3

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

18.8

10.3

A10BH05

ATC

linagliptin; oral

2.0

10.2

112

577

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

10.2

218

1371

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

10.2

132

720

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

10.2

402

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

7.5

10.2

N06AB04

ATC

citalopram; systemic

1.4

10.2

465

3437

C09AA02

ATC

enalapril; systemic

1.4

10.1

416

3014

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

10.1

110

565

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

10.1

483

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

10.1

112

580

S06.0

ICD-10 Finland

Concussion

1.6

10.0

267

1769

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.1

10.0

134

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

10.0

240

1552

N03AE01

ATC

clonazepam; systemic

1.9

10.0

134

739

ZY000

NOMESCO Finland

Hospital inpatient

2.9

10.0

156

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

9.9

322

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.6

9.9

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.4

9.9

279

R29

ICPC

Respiratory symptom/complaint other

1.7

9.8

161

943

U08

ICD-10 Finland

Personal history of COVID-19

8.1

9.8

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

9.8

299

2042

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

9.8

415

GX2D5

NOMESCO Finland

Sleep oximetry

4.4

9.8

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

9.8

318

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

9.7

631

4938

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

9.7

450

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

9.7

399

2891

NHQ40

NOMESCO Finland

Amputation of toe

3.0

9.7

137

A07DA03

ATC

loperamide; oral

2.3

9.7

332

SPAT1254

SPAT

Administration of medicine

1.5

9.7

345

2432

S18

ICPC

Laceration/cut

1.3

9.7

1078

9098

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

9.7

167

993

I50

ICD-10 Finland

Heart failure

2.4

9.6

258

A01AB09

ATC

miconazole; local oral

1.7

9.5

182

1114

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

9.5

179

1091

J01FA15

ATC

telithromycin; oral

1.6

9.4

213

1358

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

9.4

195

1218

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

9.4

156

918

N05AA02

ATC

levomepromazine; systemic

2.0

9.4

504

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.4

9.3

250

SPAT1324

SPAT

Screening procedure

0.6

9.3

139

2335

EBA05, ,

SPAT

2.6

9.2

197

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

9.2

398

A04AA01

ATC

ondansetron; systemic, rectal

1.7

9.2

172

1046

J01EA01

ATC

trimethoprim; systemic

1.4

9.2

536

4122

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

9.2

366

XF602

NOMESCO Finland

Bloodpressure monitoring

3.2

9.2

110

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

9.1

550

4250

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

9.1

340

2418

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

5.0

9.1

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.1

9.1

121

3829X

ICD-9 Finland

Suppurative and unspecified otitis media, Unspecified otitis media

11.5

9.1

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.0

9.0

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

3.0

9.0

132

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

9.0

L03AA13

ATC

pegfilgrastim; parenteral

2.0

9.0

463

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.6

9.0

188

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.6

9.0

194

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.4

9.0

254

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

9.0

505

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.1

9.0

3AC01, ,

NOMESCO Finland

3.6

8.9

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

8.9

457

3438

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

8.9

154

916

P01AB01

ATC

metronidazole; oral, rectal

1.3

8.9

897

7453

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.3

8.9

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

8.8

184

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

8.8

120

665

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

8.8

502

1XC02, ,

NOMESCO Finland

4.0

8.8

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.8

8.8

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.2

8.7

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

8.7

222

1457

R31

ICD-10 Finland

Unspecified haematuria

1.6

8.7

230

1522

C01CA24

ATC

epinephrine; parenteral

1.7

8.7

150

892

B01AC04

ATC

clopidogrel; oral

1.4

8.7

344

2473

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

8.7

348

B97.2

ICD-10 Finland

Coronavirus as the cause of diseases classified to other chapters

50.1

8.7

N03AX14

ATC

levetiracetam; systemic

2.2

8.7

322

XF402

NOMESCO Finland

ECG with work load test

1.6

8.7

228

1508

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.1

8.6

109

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

8.6

466

3538

J01DA08

ATC

[U] cefaclor

1.5

8.6

288

2005

J05AB11

ATC

valaciclovir; oral

1.5

8.6

314

2224

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

8.6

111

606

WX882

NOMESCO Finland

High dependency care

2.2

8.5

311

C09CA06

ATC

candesartan; oral

1.4

8.5

514

3968

RS221, ,

NOMESCO Finland

2.8

8.5

142

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

8.5

110

600

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.0

8.5

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.7

8.5

159

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.5

906

7574

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

20.1

8.5

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

8.5

255

L17

ICPC

Foot/toe symptom/complaint

1.3

8.4

648

5185

R06.4

ICD-10 Finland

Hyperventilation

2.9

8.4

132

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.4

8.4

231

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

8.4

420

TK820

NOMESCO Finland

Peritoneal dialysis

4.5

8.4

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

4.9

8.4

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.9

8.4

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

4.7

8.3

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

8.3

603

4785

205

Kela drug reimbursment

Chronic hypertension

1.3

8.3

555

4352

S21

ICPC

Skin texture symptom/complaint

1.5

8.3

304

2154

WX721

NOMESCO Finland

Oxygen concentrator therapy

10.8

8.3

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

8.3

192

1233

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.9

8.3

128

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

8.3

189

1210

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

8.2

430

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

8.2

269

1864

N06AB10

ATC

escitalopram; oral

1.4

8.2

491

3786

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

8.2

480

N06AX21

ATC

duloxetine; oral

1.5

8.2

258

1775

K65.0

ICD-10 Finland

Acute peritonitis

3.1

8.1

108

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

8.1

201

1311

SPAT1263

SPAT

Sampling

1.3

8.1

1009

8585

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.5

8.1

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

4.8

8.1

R4130

NOMESCO Finland

Speech therapy

2.2

8.1

292

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

8.1

108

596

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

8.1

365

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

17.2

8.1

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

17.2

8.1

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.0

8.0

114

A07AA09

ATC

vancomycin; oral

2.9

8.0

125

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.6

8.0

N06AX26

ATC

vortioxetine; oral

1.6

8.0

177

1125

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

8.0

108

599

D07AC01

ATC

betamethasone; topical

1.3

8.0

830

6908

S09.9

ICD-10 Finland

Unspecified injury of head

2.8

8.0

142

R95

ICPC

Chron obstructive pulmonary disease

2.3

7.9

269

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.9

498

3869

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.7

7.9

R28

ICPC

Limited function/disability (R)

3.0

7.9

110

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.6

7.9

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.1

7.9

362

D06AX01

ATC

fusidic acid; topical

1.5

7.9

220

1475

R07.3

ICD-10 Finland

Other chest pain

1.5

7.9

228

1541

C01DA14

ATC

isosorbide mononitrate; oral

1.4

7.8

308

2211

C10AA05

ATC

atorvastatin; oral

1.3

7.8

902

7598

N06AA09

ATC

amitriptyline; systemic

1.6

7.8

184

1186

J01DC02

ATC

cefuroxime; systemic

1.8

7.8

120

693

WX290, ,

SPAT

1.9

7.8

489

R55

ICD-10 Finland

Syncope and collapse

1.5

7.8

239

1636

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.4

7.7

203

WX199

NOMESCO Finland

Other local analgesia

2.0

7.7

372

E86

ICD-10 Finland

Volume depletion

2.3

7.7

241

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

7.7

153

947

D07AA02

ATC

hydrocortisone; topical

1.4

7.7

327

2382

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.9

7.6

123

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.2

7.6

300

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

7.6

161

1012

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

7.6

521

R52.2

ICD-10 Finland

Other chronic pain

1.9

7.6

443

A08

ICPC

Swelling

1.8

7.6

103

572

M05BX04

ATC

denosumab; parenteral

1.8

7.6

110

624

48509

ICD-8 Finland

Bronchopneumonia, unspecified

3.1

7.6

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

7.5

515

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.2

7.5

262

N20.0

ICD-10 Finland

Calculus of kidney

2.4

7.5

218

A97

ICPC

No disease

1.4

7.5

412

3130

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

10.0

7.5

A10AB04

ATC

insulin lispro; parenteral

2.0

7.5

403

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

7.5

126

745

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.7

7.5

141

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

7.4

212

1428

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

7.4

112

643

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

2.3

7.4

239

T74.1

ICD-10 Finland

Physical abuse

2.3

7.4

233

Z51.5

ICD-10 Finland

Palliative care

1.6

7.3

156

982

D07AB08

ATC

desonide; topical

1.5

7.3

238

1647

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.3

305

2213

KH1AD

NOMESCO Finland

CT of urinary organs

2.0

7.3

400

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.4

7.3

L04AX03

ATC

methotrexate; systemic

1.5

7.3

211

1426

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

7.3

132

798

B03XA01

ATC

erythropoietin; parenteral

3.5

7.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

7.3

130

783

A10BJ06

ATC

semaglutide; parenteral

1.8

7.2

107

610

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

7.2

500

3935

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

2.8

7.2

127

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.8

7.2

127

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

7.2

207

1397

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

7.2

220

1504

C10AA01

ATC

simvastatin; oral

1.3

7.2

864

7301

RD210, ,

NOMESCO Finland

2.5

7.2

180

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

7.2

192

1276

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

30.1

7.1

T82

ICPC

Obesity

1.9

7.1

467

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

7.1

262

1857

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

7.1

104

591

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

7.1

197

1319

WX320

NOMESCO Finland

Spinalanesthesy

1.3

7.1

524

4160

XF622

NOMESCO Finland

Measurement of minute volume of heart

6.6

7.1

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.3

7.1

237

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

7.1

276

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

12.0

7.1

WX780

NOMESCO Finland

Remote monitoring CPAP

1.8

7.1

103

585

WW400

NOMESCO Finland

Plasmaferesis

10.0

7.0

A10BH01

ATC

sitagliptin; oral

1.5

7.0

195

1306

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

7.0

127

767

D64.8

ICD-10 Finland

Other specified anaemias

2.5

7.0

170

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

7.0

365

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

7.0

284

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.0

139

861

T89

ICPC

Diabetes insulin dependent

1.8

7.0

102

580

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

7.0

393

H26.3

ICD-10 Finland

Drug-induced cataract

3.9

7.0

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

7.0

103

588

4451

FHL

Guitar cutting

1.9

6.9

472

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.7

6.9

130

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

6.9

136

840

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.3

6.9

227

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.9

1525

13747

S10

ICPC

Boil/carbuncle

1.7

6.9

131

802

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

13.8

6.9

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

6.9

133

818

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.4

6.9

190

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

6.9

561

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

6.9

260

1240

FHL

Bronchoscopy

3.2

6.8

B37.0

ICD-10 Finland

Candidal stomatitis

3.2

6.8

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.5

6.8

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

3.4

6.8

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.4

6.8

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.1

6.8

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.8

886

7547

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.2

6.8

248

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

6.8

899

7671

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

6.8

104

600

UJD02

NOMESCO Finland

Gastroscopy

1.8

6.7

542

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.9

6.7

104

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

6.7

159

1028

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.7

619

5060

GBB00

NOMESCO Finland

Tracheostomy

2.9

6.7

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.3

6.7

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

6.7

115

686

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

22.6

6.7

M54

ICD-10 Finland

Dorsalgia

1.4

6.6

279

2027

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

6.6

102

589

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

6.6

106

619

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

6.6

153

983

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

6.6

118

710

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.4

6.6

187

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

6.6

186

1250

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

12.3

6.6

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

6.5

188

1269

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

6.5

1356

12117

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.0

6.5

312

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

2.1

6.5

292

N17

ICPC

Vertigo/dizziness

1.4

6.5

249

1778

5AB14, ,

NOMESCO Finland

10.0

6.5

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.0

6.5

340

J43.2

ICD-10 Finland

Centrilobular emphysema

6.8

6.5

H01

ICPC

Ear pain/earache

1.4

6.5

255

1830

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

6.5

504

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

6.5

313

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

6.5

101

586

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

6.5

418

U09

ICD-10 Finland

Post COVID-19 condition

2.9

6.5

101

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.5

359

2732

L12

ICPC

Hand/finger symptom/complaint

1.4

6.5

360

2741

WPB10

NOMESCO Finland

Making a convalescent care decision

6.2

6.5

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

6.2

6.5

EB1SA, ,

SPAT

1.7

6.5

123

754

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

6.5

197

1347

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

6.4

354

2691

G04CA02

ATC

tamsulosin; oral

1.3

6.4

523

4206

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.9

6.4

442

H60

ICD-10 Finland

Otitis externa

1.7

6.4

123

757

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.8

6.4

464

M10

ICD-10 Finland

Gout

1.8

6.3

560

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

6.3

223

1569

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

6.5

6.3

J02AC03

ATC

voriconazole; systemic

8.2

6.3

N05BB01

ATC

hydroxyzine; systemic

1.6

6.3

134

844

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.8

6.3

108

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.9

6.3

372

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.5

6.3

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.5

6.3

L01XX52

ATC

venetoclax; oral

9.3

6.3

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

9.3

6.3

1518, ,

Kela drug reimbursment

9.3

6.3

399

Kela drug reimbursment

Venetoclax

9.3

6.3

WW200, ,

SPAT

0.7

6.3

308

4060

D10

ICPC

Vomiting

1.6

6.3

141

901

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

6.3

336

2543

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.5

6.3

149

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.1

6.3

250

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

18.0

6.3

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.8

6.3

103

AK1

HTX (heart transplant)

+∞

6.3

77700

ICD-8 Finland

Immaturity, unqualified, Tempus graviditatis breve (minus quarn 35 hebdomadum), ponderis et longitudinis ratione non habita

+∞

6.3

48000, ,

ICD-8 Finland

+∞

6.3

N03AX09

ATC

lamotrigine; oral

1.7

6.2

113

684

R25.1

ICD-10 Finland

Tremor, unspecified

2.0

6.2

332

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

3.7

6.2

D07AC13

ATC

mometasone; topical

1.3

6.2

644

5336

U14

ICPC

Kidney symptom/complaint

2.5

6.2

144

U13

ICPC

Bladder symptom/complaint other

2.0

6.2

312

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

6.2

167

1113

V03AE03

ATC

lanthanum carbonate; oral

5.0

6.2

R06AX27

ATC

desloratadine; oral

1.3

6.2

656

5450

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

6.1

180

1221

SPAT1260

SPAT

Consultation of another employee

1.3

6.1

380

2940

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

7.7

6.1

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.7

6.1

D02

ICPC

Abdominal pain epigastric

1.6

6.1

127

797

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

6.1

168

1125

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.3

6.1

182

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.7

6.1

116

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

12.5

6.1

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.0

6.1

N20.1

ICD-10 Finland

Calculus of ureter

1.8

6.1

471

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.0

6.1

294

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

8.6

6.0

SPAT1127

SPAT

Enema

3.6

6.0

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.1

6.0

254

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

6.0

146

950

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.5

6.0

140

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

6.0

202

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

866

2277

4.98

313.04

2.4

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1096

3496

4.41

308.44

5.5

3.5

0.82

mmol/l

0.07

1065

3303

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

892

2429

4.84

308.29

5.6

4.3

265.05

245.72

u/l

2.61

874

2297

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

865

2301

4.92

307.73

2.5

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1165

3322

5.16

307.65

2.8

1.8

—

(3023368) Bacteria identified in Blood by Culture

1728

5729

5.91

307.65

7.3

4.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1555

4874

5.67

307.65

3.6

1.8

1.38

1.12

mg/l

1.84

1388

3621

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

553

679

9.81

307.65

3.1

2.8

4.84

3.46

g/l

42.96

548

644

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

537

798

8.02

307.65

2.6

2.0

1.17

1.96

ug/l

0.73

502

703

(3022096) Basophils/100 leukocytes in Blood

1992

10337

3.90

263.29

11.0

6.1

0.49

0.67

36.08

1950

9681

(40760892) CBC W Ordered Manual Differential panel - Blood

2032

10752

3.90

259.07

12.2

6.3

—

(3006504) Eosinophils/100 leukocytes in Blood

2016

10681

3.84

254.89

11.1

6.0

2.10

2.83

40.79

1975

10017

(3019069) Monocytes/100 leukocytes in Blood

2018

10742

3.82

252.27

11.4

6.3

8.28

8.61

4.67

1979

10092

(3014111) Lactate [Moles/volume] in Serum or Plasma

705

1867

4.66

247.57

18.2

7.5

1.27

1.40

mmol/l

2.52

695

1820

(3001604) Monocytes [#/volume] in Blood

2070

11382

3.79

241.90

10.5

5.8

0.61

0.58

e9/l

5.41

1758

9905

(3006315) Basophils [#/volume] in Blood

2071

11399

3.79

241.44

10.5

5.8

0.04

e9/l

2.25

1759

9917

(3018010) Neutrophils/100 leukocytes in Blood

2016

10923

3.71

240.57

10.7

5.8

61.49

56.72

47.85

1979

10280

(3002030) Lymphocytes/100 leukocytes in Blood

2032

11101

3.71

238.50

11.3

6.0

24.09

28.48

45.68

1994

10460

(3019198) Lymphocytes [#/volume] in Blood

2091

11765

3.71

231.23

10.6

5.9

2.07

1.94

e9/l

0.56

1804

10468

(3013115) Eosinophils [#/volume] in Blood

2091

11782

3.71

230.31

11.4

6.1

0.17

0.19

e9/l

5.62

1795

10393

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

500

1052

5.53

230.08

22.8

10.5

24.78

24.15

mmol/l

3.77

490

1026

(3000991) Gas panel - Venous blood

669

1797

4.53

229.38

21.0

8.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1055

4159

3.40

204.17

5.1

3.5

336.96

468.40

ng/l

0.64

865

3124

(3003396) Base excess in Arterial blood by calculation

750

2370

3.91

203.94

18.1

7.8

1.12

0.92

mmol/l

0.64

643

1853

(3021901) Oxygen saturation in Capillary blood

287

387

8.11

203.56

5.2

2.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

749

2370

3.90

203.21

18.7

7.8

5.03

5.08

kpa

0.53

725

2272

(3027801) Oxygen [Partial pressure] in Arterial blood

748

2370

3.90

202.48

18.7

7.8

10.52

12.63

kpa

27.53

720

2273

(3020779) Urea [Moles/volume] in Serum or Plasma

672

1976

4.12

202.19

13.4

7.8

9.96

9.48

mmol/l

0.87

659

1895

(3006184) Hemoglobin [Mass/volume] in Capillary blood

300

451

7.30

193.09

3.8

2.2

126.75

131.18

g/l

1.61

238

350

(3013650) Neutrophils [#/volume] in Blood by Automated count

2157

13165

3.42

192.17

16.3

8.8

4.39

4.06

e9/l

8.49

1872

11506

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

129

28.66

191.55

1.4

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

306

496

6.77

183.32

2.5

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

113

34.53

178.02

1.4

1.1

99.11

86.26

ng/l

0.07

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

472

1189

4.54

172.87

2.1

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

282

448

6.86

171.99

5.0

2.3

15.81

16.48

1.48

210

227

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

501

1329

4.34

171.50

6.5

4.0

2.20

1.60

mmol/l

3.42

413

977

(3009343) pH of Capillary blood

510

1375

4.28

170.82

6.7

4.0

7.43

7.41

4.58

167

161

(3003458) Phosphate [Moles/volume] in Serum or Plasma

788

2859

3.40

170.43

11.0

6.3

1.07

1.04

mmol/l

1.35

766

2665

(1616796) Gas panel - Central venous blood

288

479

6.56

167.96

6.5

3.7

—

(3016502) Oxygen saturation in Arterial blood

655

2143

3.65

166.18

20.6

8.2

93.87

95.85

9.75

637

2071

(3021589) Normoblasts [#/volume] in Blood

1763

10156

2.85

162.79

20.0

9.1

0.00

e9/l

0.56

1384

8316

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

285

484

6.42

162.72

2.6

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

1336

6677

2.84

162.35

5.3

3.2

39.81

77.62

e6/l

1.83

1062

5115

(3030467) Casts [#/volume] in Urine by Automated count

1255

6102

2.85

160.27

4.9

3.0

0.46

0.41

e6/l

0.35

985

4613

(3033658) Prothrombin time (PT) actual/Normal

1195

5667

2.87

159.97

7.2

4.0

90.93

89.72

0.89

1178

5528

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

238

342

7.49

159.03

2.2

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1740

10041

2.80

158.62

4.2

2.8

311.92

121.83

ug/l

42.02

1680

9324

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

212

270

8.39

157.13

2.2

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1890

11431

2.84

156.30

11.6

6.1

10.31

11.84

umol/l

9.30

1827

10851

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

334

684

5.38

156.26

3.7

3.2

0.31

0.34

u/ml

0.72

170

390

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

237

353

7.22

153.21

2.6

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1793

10626

2.77

153.05

17.6

6.7

1.19

1.21

mmol/l

24.30

1589

9033

(3002173) Hemoglobin [Mass/volume] in Arterial blood

605

1994

3.56

150.62

21.8

8.4

122.46

123.35

g/l

0.42

595

1944

(3018095) Leukocytes [#/volume] in Urine

1459

7865

2.70

149.47

6.1

3.6

82.74

102.31

e6/l

0.41

1082

5524

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

192

231

8.82

148.94

2.6

1.7

—

(3002032) Base excess in Venous blood by calculation

604

2004

3.54

148.68

6.6

4.2

1.77

1.78

mmol/l

0.03

541

1643

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2340

16136

3.24

146.61

3.8

3.1

—

(3012544) pH of Venous blood

610

2069

3.46

144.76

6.7

4.2

7.38

0.01

(3021447) Carbon dioxide [Partial pressure] in Venous blood

600

2014

3.49

144.75

6.6

4.2

5.82

5.83

kpa

0.07

589

1952

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1660

9666

2.66

143.41

16.3

6.0

1.19

1.21

mmol/l

22.84

1584

8832

(3014007) Fractional oxyhemoglobin in Arterial blood

459

1321

3.93

139.02

26.4

9.8

92.89

94.16

5.23

459

1313

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

191

252

8.04

137.22

2.2

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

202

286

7.51

136.48

2.5

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

436

1232

3.98

135.35

1.6

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

148

143

10.85

134.99

2.2

1.7

—

(36304419) Bacteria [Presence] in Urine

1186

6016

2.63

133.85

4.9

3.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2014

13163

2.70

132.92

13.7

4.7

6.97

6.69

mmol/l

6.69

1947

12279

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

199

296

7.14

128.50

2.1

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1583

9399

2.49

125.31

7.8

4.9

33.82

35.94

g/l

33.02

1505

8769

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

800

3452

2.81

122.87

3.9

2.9

2.28

2.21

e6/l

0.08

445

1855

(3018677) aPTT in Platelet poor plasma by Coagulation assay

790

3412

2.80

120.87

3.8

2.2

30.55

29.81

2.23

775

3305

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

241

487

5.30

113.66

9.8

5.8

2049.08

399.44

iu/ml

1.09

(3018418) pH of Serum or Plasma

1162

6206

2.45

113.21

8.1

4.0

7.40

0.59

305

1216

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

816

3698

2.67

112.55

3.8

2.7

0.87

1.02

e6/l

0.90

455

2089

(3005719) IgG [Mass/volume] in Serum or Plasma

497

1742

3.23

109.68

4.7

2.7

9.37

10.64

g/l

6.78

475

1592

(3017181) Myelocytes/100 leukocytes in Blood

511

1831

3.17

108.59

6.2

4.2

0.98

0.88

0.45

288

616

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

380

1140

3.68

107.09

23.5

10.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

121

122

10.30

106.95

2.4

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1589

9943

2.31

104.95

18.9

14.3

1.24

1.26

inr

0.41

577

2966

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1077

5719

2.40

104.51

4.5

3.0

1837.13

1392.61

ng/l

1.89

969

4808

(3021440) Promyelocytes/100 leukocytes in Blood

487

1744

3.15

103.26

6.2

4.2

0.08

0.10

0.43

266

530

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

671

2878

2.73

102.11

4.0

2.6

22.08

23.56

1.84

615

2477

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

191

346

5.84

101.31

2.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

191

346

5.84

101.31

2.3

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

470

1668

3.17

101.07

5.8

4.0

0.67

0.65

0.14

264

528

(3000850) Epithelial cells [#/volume] in Urine

921

4618

2.45

101.01

4.5

2.5

5.64

5.74

e6/l

0.08

851

4146

(3024354) Oxygen [Partial pressure] in Venous blood

467

1670

3.14

99.01

5.4

3.6

5.02

4.63

kpa

2.17

454

1617

(3022948) Iron [Moles/volume] in Serum or Plasma

734

3345

2.59

98.43

3.9

2.5

12.15

13.54

umol/l

4.93

697

3124

(3004789) Transferrin [Mass/volume] in Serum or Plasma

691

3069

2.64

97.60

3.9

2.5

2.25

2.33

g/l

3.10

657

2848

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

126

154

8.50

96.17

2.6

1.6

—

(3025159) Blasts/100 leukocytes in Blood

459

1655

3.10

95.76

6.0

4.3

0.03

0.31

0.82

236

440

(3036489) Thrombin time

314

894

3.81

95.17

2.8

2.3

21.70

21.33

0.51

295

793

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

106

105

10.44

94.81

2.5

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

106

105

10.44

94.81

2.5

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2307

17320

2.56

94.78

14.4

7.2

80.77

77.49

u/l

3.00

2249

16356

(3012501) Base excess in Blood by calculation

222

488

4.84

94.63

7.2

4.3

2.43

2.48

mmol/l

0.10

157

319

(3026782) Osmolality of Urine

868

4392

2.39

91.89

4.5

2.8

525.83

551.34

mosm/kgh2o

2.92

779

3775

(3015377) Calcium [Moles/volume] in Serum or Plasma

1225

7168

2.22

91.56

4.4

3.3

2.32

2.35

mmol/l

11.07

1141

6371

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

190

377

5.32

91.18

4.5

3.2

264.55

1617.83

u/ml

0.90

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

784

3804

2.45

91.05

3.0

2.46

2.44

mmol/l

3.41

729

3353

(40758558) Short blood count panel - Blood

1030

5645

2.27

90.10

10.5

6.7

—

(3042936) Bacteria identified in Isolate by Culture

678

3108

2.54

88.77

2.8

2.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

194

402

5.10

88.58

2.0

1.5

—

(3010421) pH of Blood

238

589

4.31

87.31

7.3

4.1

7.42

1.14

220

524

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

242

611

4.23

86.45

3.1

2.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

413

1507

3.03

83.78

2.0

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

170

338

5.28

81.30

4.7

3.6

1.61

1.35

0.40

158

307

(3027945) Reticulocytes/100 erythrocytes in Blood

555

2421

2.59

79.81

4.7

2.8

1.88

1.75

1.92

512

2157

(3028026) IgM [Mass/volume] in Serum or Plasma

378

1364

3.03

77.94

3.1

1.9

1.38

1.42

g/l

0.10

348

1258

(3031040) Bacteria [#/volume] in Urine by Automated count

2005

14756

2.14

76.86

6.5

4.1

206.85

1586.34

e6/l

2.06

206

(3023419) Bacteria identified in Sputum by Culture

143

262

5.69

74.74

3.0

2.2

—

(3023520) Reticulocytes [#/volume] in Blood

435

1756

2.73

72.61

4.5

2.8

72.10

69.82

e9/l

0.57

302

1328

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

294

962

3.29

71.35

2.5

1.8

1.59

1.51

g/l

0.70

261

838

(3037467) Urinalysis macro (dipstick) panel - Urine

2074

15695

2.10

70.52

6.4

4.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

567

2637

2.43

70.33

2.2

1.7

—

(3026008) Bacteria identified in Urine by Culture

1050

6266

2.05

70.00

4.0

2.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

408

1660

2.69

66.75

3.9

2.7

64.83

66.70

g/l

4.77

380

1529

(3026250) Tacrolimus [Mass/volume] in Blood

115

8.04

66.11

45.6

36.1

7.49

7.37

ug/l

0.18

105

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

109

173

6.51

65.88

3.2

3.7

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

130

246

5.48

65.57

2.4

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

130

246

5.48

65.57

2.4

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1059

6477

1.99

64.78

3.0

2.1

351.94

241.22

u/l

0.82

1016

6089

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

467

2082

2.48

63.02

3.2

2.5

37.26

61.28

u/l

0.53

402

1780

(3044640) Blood type and Crossmatch panel - Blood

1120

7065

1.95

61.96

3.6

2.3

—

(3019060) Gas panel - Arterial blood

348

1361

2.77

61.25

6.6

5.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1178

7583

1.93

61.12

4.3

3.2

42.98

35.41

u/l

0.40

1128

7198

(3022313) Gas panel - Capillary blood

287

1015

3.03

60.77

6.7

4.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

124

242

5.31

60.43

59.0

7.6

7.19

7.17

mmol/l

0.02

115

208

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

163

409

4.16

58.41

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

163

409

4.16

58.41

1.5

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

922

5543

1.97

57.95

2.8

2.2

3.05

2.86

mg/l

1.39

813

4716

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

111

209

5.48

56.26

2.3

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

205

620

3.48

56.11

2.2

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1227

8178

1.86

55.74

5.9

3.4

232.11

54.11

ng/l

0.59

909

5398

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1313

8964

1.84

54.99

2.9

2.2

72.36

75.18

nmol/l

3.21

1211

8121

(46235355) HIV 1 and 2 tests - Meaningful Use set

863

5175

1.95

53.95

2.2

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

259

923

2.98

53.94

2.0

1.5

20.52

14.47

u/ml

0.28

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

114

231

5.09

53.22

2.3

1.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

198

606

3.43

53.16

4.8

3.6

11.11

1.72

ratio

—

(3000494) Fungus identified in Specimen by Culture

516

2572

2.22

53.16

1.9

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

331

1360

2.62

52.53

3.8

2.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

319

1287

2.66

52.52

6.1

3.4

125.79

130.05

g/l

2.42

311

1253

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

472

2288

2.27

51.95

5.5

3.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

199

621

3.37

51.80

5.2

3.6

52.38

67.04

mg/l

0.28

145

503

(3034860) Kappa light chains.free [Mass/volume] in Serum

199

621

3.37

51.80

5.2

3.6

52.59

68.51

mg/l

0.65

144

503

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

137

6.44

51.76

1.4

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

10.55

50.90

1.3

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

933

5831

1.88

50.87

4.6

2.7

2399.33

4961.94

umol/l

1.51

852

5159

(3017354) Segmented neutrophils/100 leukocytes in Blood

103

203

5.22

49.62

3.9

3.6

58.95

54.81

0.84

177

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

171

5.65

49.44

2.0

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

171

5.65

49.44

2.0

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

171

5.65

49.44

2.0

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1257

8679

1.79

48.97

2.2

1.9

91.94

95.33

pmol/l

1.85

693

4675

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

874

5406

1.88

48.85

3.5

2.3

—

(3000492) Spirometry study

465

2295

2.22

48.77

1.8

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

434

2090

2.26

48.29

2.4

2.1

334.41

377.18

nmol/l

3.86

407

1923

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

171

507

3.52

48.18

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

380

1731

2.37

48.14

8.4

3.9

1.21

1.23

mmol/l

5.43

362

1496

(3037692) Legionella sp identified in Specimen by Organism specific culture

9.21

46.94

1.8

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

211

726

3.05

46.62

3.2

2.3

1544.48

444.81

ug/l

0.49

205

683

(3042733) HLA Ab [Presence] in Serum

7.86

46.39

4.7

4.6

—

(3024928) Oxygen saturation in Venous blood

161

473

3.54

45.99

4.8

3.7

—

(3019977) pH of Arterial blood

115

6.58

45.61

2.2

2.9

7.43

7.42

0.30

(3035350) Ketones [Presence] in Urine by Test strip

1513

11170

1.73

45.40

5.2

3.4

0.00

estimate

1.23

377

2259

(3009261) Glucose [Presence] in Urine by Test strip

1522

11257

1.73

45.35

5.2

3.4

0.00

estimate

0.80

345

2063

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

160

473

3.52

45.26

1.7

1.5

112.63

116.29

u/ml

0.12

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2667

23520

2.49

44.98

34.5

12.7

31.07

23.44

mg/l

27.32

2484

18330

(3027273) Bicarbonate [Moles/volume] in Venous blood

253

983

2.72

44.66

7.7

3.5

25.16

25.08

mmol/l

0.15

247

946

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

182

589

3.23

44.59

1.5

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

1506

11144

1.72

44.46

7.1

4.6

0.00

estimate

0.50

364

2158

(3017143) Hepatitis C virus Ab [Presence] in Serum

560

3090

2.00

43.33

2.0

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

168

527

3.32

43.29

1.4

1.3

254.94

259.38

u/ml

0.06

118

329

(3021960) Folate [Moles/volume] in Serum or Plasma

791

4900

1.84

43.07

1.8

1.5

20.06

20.28

nmol/l

0.15

721

4222

(3007164) IgA [Mass/volume] in Serum or Plasma

762

4669

1.85

42.96

2.3

1.5

2.37

2.38

g/l

0.03

522

2914

(3015736) pH of Urine

1271

9039

1.72

42.85

4.4

3.1

5.76

5.84

0.40

748

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

172

554

3.24

42.45

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

205

735

2.92

42.04

1.9

1.6

490.00

257.14

titre

—

(4200892) Spirometry reversibility

318

1418

2.39

42.03

1.5

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2061

16771

1.77

42.00

6.4

3.8

16.01

11.00

mm/h

28.09

1977

15543

(3021879) Hepatitis B virus core Ab [Presence] in Serum

402

1986

2.19

41.65

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1447

10724

1.69

41.34

3.6

2.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

210

775

2.84

40.82

3.1

1.8

—

(3042631) Mycobacterium sp identified in Specimen

107

257

4.28

40.57

2.9

2.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

160

510

3.26

40.16

1.7

1.6

—

(3011412) CD3 cells [#/volume] in Blood

228

4.46

39.62

2.5

2.4

1.04

1.25

e9/l

1.53

205

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

222

860

2.71

39.32

3.4

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

150

466

3.34

39.24

6.0

3.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

745

2.82

38.73

2.7

2.5

7.55

7.34

g/l

0.93

188

680

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

745

2.82

38.73

2.7

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

745

2.82

38.73

2.7

2.5

3.53

3.68

g/l

0.95

189

680

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

192

702

2.86

37.94

2.7

2.5

9.70

10.32

g/l

1.05

178

637

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

469

2538

2.01

37.91

4.4

2.9

6.80

8.34

umol/l

1.47

408

2214

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

185

665

2.90

37.72

5.9

4.8

1.85

1.48

mg/l

5.66

178

616

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

102

6.29

37.32

2.0

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

102

6.29

37.32

2.0

2.1

—

(3037522) Nuclear Ab [Titer] in Serum

527

2989

1.93

37.10

1.5

1.3

507.35

513.76

titre

0.03

117

596

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

167

4.96

37.07

2.2

2.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2500

21870

1.98

36.88

30.4

11.8

82.21

84.61

ml/min/173m2

4.58

2159

17871

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

677

4174

1.81

36.57

2.0

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

188

699

2.81

35.99

2.8

2.5

3.10

2.96

g/l

0.97

176

635

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

177

643

2.87

35.38

3.2

2.6

0.86

1.12

g/l

0.40

147

563

(3002385) Erythrocyte distribution width [Ratio]

2373

20497

1.83

35.26

37.2

15.2

14.47

14.83

0.90

2358

20116

(3048929) Epstein Barr virus Ab [Presence] in Serum

220

897

2.57

35.10

1.4

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

6.73

34.85

2.1

2.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

7.65

34.84

2.3

2.2

—

(40768446) Kidney Pathology biopsy report

103

6.03

34.67

2.0

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

120

354

3.49

34.04

1.4

1.8

0.55

0.83

g/l

2.83

280

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

991

6902

1.66

34.04

3.6

2.5

53.00

71.02

u/l

0.91

928

6379

(3019550) Sodium [Moles/volume] in Serum or Plasma

2639

23713

2.14

33.43

38.5

14.6

139.16

139.65

mmol/l

20.62

2612

23096

(3042111) Morphology [Interpretation] in Bone marrow Narrative

122

368

3.42

33.43

1.8

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

356

1821

2.09

33.33

3.0

2.3

11.42

7.07

ug/l

1.59

308

1619

(3005322) IgE [Units/volume] in Serum or Plasma

292

1386

2.23

33.08

1.5

1.3

181.51

217.55

u/ml

0.46

267

1273

(3011397) Hemoglobin [Presence] in Urine by Test strip

776

5103

1.71

32.94

4.1

3.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

111

5.59

32.09

36.4

25.6

129.96

120.75

ug/l

0.38

(3023103) Potassium [Moles/volume] in Serum or Plasma

2639

23795

2.10

31.81

39.1

14.7

3.97

mmol/l

0.17

2610

23136

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

201

825

2.54

31.59

1.5

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

334

1705

2.08

31.36

4.2

2.7

243.22

183.18

ng/l

1.37

307

1553

(3030905) Polymorphonuclear cells [#/volume] in Blood

134

446

3.10

31.27

4.2

3.6

4.10

4.08

e9/l

0.04

134

446

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1939

16080

1.61

31.02

4.2

3.0

53.49

47.54

u/l

2.47

1844

15120

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

136

462

3.04

30.64

5.1

3.9

58.08

57.29

0.28

136

462

(3013512) EKG study

884

6113

1.64

30.53

5.3

3.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

382

2067

1.98

30.47

2.6

2.3

0.22

g/l

0.20

355

1933

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

306

1531

2.12

30.26

6.7

4.2

123.30

89.72

ng/l

3.58

264

1350

(4062490) Immunoglobulin typing, IgG

210

4.09

30.24

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

256

3.76

30.04

1.5

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

271

3.67

29.87

7.8

6.3

11.42

11.49

mg/l

0.05

252

(3027135) IgG subclass 1 [Mass/volume] in Serum

208

4.08

29.78

1.2

1.3

6.47

6.78

g/l

0.23

149

(3024139) IgG subclass 3 [Mass/volume] in Serum

208

4.08

29.78

1.2

1.3

0.40

0.39

g/l

0.04

148

(3028192) IgG subclass 2 [Mass/volume] in Serum

209

4.06

29.59

1.2

1.3

2.67

3.05

g/l

0.76

149

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

4.32

29.13

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

240

3.75

28.08

5.4

4.4

—

(3017569) Oxygen content in Arterial blood

103

5.42

28.07

1.7

2.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

245

3.72

28.01

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

107

5.32

27.96

1.3

1.2

120.06

84.09

u/l

1.36

(3020682) Albumin/Creatinine [Ratio] in Urine

914

6507

1.59

27.39

5.2

3.9

18.53

11.93

mg/mmol

1.10

622

4225

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

187

4.09

27.11

1.3

1.2

67.33

63.45

u/l

0.17

173

(3024932) HLA-DR beta [Type]

5.93

26.98

1.1

—

(3024471) HLA-A [Type]

5.86

26.65

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

148

569

2.69

26.53

2.4

2.5

0.05

0.01

g/l

0.44

139

527

(3044889) 12 lead EKG panel

1874

15730

1.53

25.67

4.8

3.5

—

(40761536) Microorganisms panel - Urine sediment

356

1993

1.89

25.44

7.1

3.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

119

417

2.93

25.39

1.9

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

149

588

2.62

25.36

2.3

2.4

36.07

37.72

g/l

2.13

137

524

(3000012) Reticulocyte production index

287

3.35

25.31

3.2

2.2

—

(3004451) EKG impression Narrative

106

5.07

25.16

1.5

1.2

—

(3037756) Immunofixation for Serum or Plasma

118

414

2.93

25.13

2.1

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.84

24.93

3.6

4.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

139

535

2.68

24.87

2.4

2.5

0.00

g/l

-0.00

130

496

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

140

541

2.67

24.85

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

155

635

2.52

24.43

1.3

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

103

5.02

23.95

1.3

1.2

42.56

16.27

u/l

2.65

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.29

23.90

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

943

6934

1.53

23.74

4.3

3.3

7.55

8.04

mmol/l

2.36

801

5902

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

136

531

2.64

23.65

2.4

2.5

0.00

g/l

-0.00

130

495

(3019309) Folate [Moles/volume] in Red Blood Cells

582

3845

1.64

23.16

2.0

1.7

1172.94

1164.38

nmol/l

0.07

456

2926

(3008152) Bicarbonate [Moles/volume] in Arterial blood

258

1337

2.02

23.04

11.6

7.2

24.52

24.40

mmol/l

0.18

246

1276

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

289

3.22

23.01

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.07

22.80

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

301

3.16

22.79

1.4

1.2

—

(3012516) Albumin [Mass/volume] in Urine

854

6200

1.53

22.58

4.5

3.3

556.30

326.97

mg/l

0.68

603

4083

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

151

4.10

22.30

1.2

1.3

4.84

1.18

u/ml

0.83

(3003434) Protein [Mass/volume] in Pleural fluid

235

3.43

22.18

1.7

1.5

30.24

32.31

g/l

0.64

209

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

104

367

2.90

21.94

1.2

1.1

—

(4035726) Immunohistochemistry procedure

324

1843

1.85

21.89

1.7

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2362

21148

1.60

21.86

5.3

4.4

1.88

2.00

mu/l

0.81

2212

19492

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

183

848

2.24

21.84

8.6

5.5

1.55

1.68

1.18

176

794

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

304

3.09

21.78

2.3

2.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

181

838

2.24

21.65

8.8

5.6

0.80

0.90

2.71

175

788

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.18

21.62

5.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

159

3.96

21.62

1.6

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

102

362

2.88

21.30

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

337

2.94

21.05

1.1

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

140

587

2.45

21.01

2.3

2.1

10.70

11.12

mg/l

0.23

133

545

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

249

3.27

20.93

1.4

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

103

376

2.80

20.43

1.5

1.2

2.27

4.42

u/ml

1.27

130

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

32.77

20.18

1.5

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

193

3.53

19.79

2.4

2.3

640.08

760.35

e6/l

0.91

188

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

120

4.22

19.07

1.6

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

120

4.22

19.07

1.6

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2679

24981

1.85

19.07

35.4

14.7

85.45

77.84

umol/l

10.16

2679

24971

(3012441) Differential panel - Pleural fluid

190

3.48

18.79

1.7

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

190

951

2.07

18.62

2.4

1.9

36.24

38.81

u/l

0.94

172

850

(3023183) Ammonium ion [Moles/volume] in Plasma

119

493

2.47

18.35

4.3

3.0

32.61

35.30

umol/l

0.55

111

455

(40768797) Stomach Pathology biopsy report

445

2910

1.62

18.06

1.3

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

6.30

18.01

2.4

1.1

94.10

89.02

0.28

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.87

17.78

2.4

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.87

17.78

2.4

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

372

2.66

17.54

1.5

1.2

3.66

5.03

u/ml

0.64

172

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.81

17.53

2.4

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

172

3.48

17.15

2.4

481.18

528.14

e6/l

0.36

146

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2676

25072

1.78

16.97

19.1

9.6

31.87

27.53

u/l

6.54

2635

24261

(3016650) Hepatitis A virus Ab [Presence] in Serum

103

414

2.54

16.95

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

229

3.11

16.92

1.2

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

256

2.98

16.85

2.7

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

154

749

2.11

16.29

1.7

1.6

0.24

0.28

iu/ml

0.07

135

(3011648) Oxygen content in Venous blood

193

3.26

16.28

3.6

4.3

10.61

11.33

0.67

193

(40768804) Tissue Pathology biopsy report

1100

8801

1.40

16.26

2.3

2.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

110

4.05

15.94

6.5

3.7

—

(3028433) Virus identified in Specimen by Culture

4.97

15.93

1.5

1.3

—

(40768806) Pleura Pathology biopsy report

191

3.24

15.87

1.7

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

197

3.19

15.75

1.2

167.50

248.29

titre

0.29

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

375

2.56

15.73

6.9

3.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1984

17568

1.40

15.52

4.4

3.7

14.65

14.71

pmol/l

0.43

1858

16016

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

123

3.78

15.21

1.9

1.5

4.30

6.11

u/l

0.40

106

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

13.11

15.16

2.7

2.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

813

6234

1.42

15.11

5.5

3.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.17

15.10

1.5

1.2

—

(3025941) Bacteria identified in Stool by Culture

225

1290

1.81

14.71

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

230

2.91

14.34

1.7

1.4

22.40

27.33

iu/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

199

3.06

14.22

1.7

1.4

49139.61

84948.17

e6/l

0.38

119

(3008536) Aspergillus sp Ab [Presence] in Serum

6.20

14.20

2.2

2.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

281

1738

1.68

14.05

3.3

2.6

56.07

69.20

ml/min/173m2

4.70

119

659

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

165

3.25

13.95

2.5

2.4

0.19

0.21

e9/l

0.31

145

(3045788) Cell count panel - Pleural fluid

173

3.16

13.58

1.7

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

205

2.97

13.52

1.5

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

222

2.88

13.44

1.7

1.4

1866.02

1725.46

e6/l

0.13

160

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

154

3.29

13.40

2.5

2.7

33.11

42.72

2.14

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

630

4706

1.43

13.29

1.7

1.6

—

(21494434) Karyotype in Bone marrow

202

2.96

13.25

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

127

622

2.09

13.23

3.7

3.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

353

2.45

13.12

1.2

1.1

120.72

114.73

0.79

324

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

361

2.42

12.97

1.4

1.2

46.69

46.95

u/l

0.00

313

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

416

2.30

12.60

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2274

20866

1.40

12.59

7.1

5.3

40.87

39.43

mmol/mol

8.40

2167

19455

(3047181) Lactate [Moles/volume] in Blood

134

684

2.01

12.49

9.3

6.3

1.48

1.29

mmol/l

0.57

121

600

(3002256) Pathology report gross observation

399

2770

1.51

12.17

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

348

2.40

12.10

1.9

1.3

—

(3020891) Body temperature

154

848

1.86

11.49

7.7

4.6

—

(3009871) Measles virus Ab [Titer] in Serum

3.98

11.46

1.3

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

141

757

1.91

11.38

6.5

4.1

1.27

1.39

mmol/l

0.94

135

746

(40761511) CBC panel - Blood by Automated count

2610

24678

1.53

11.36

25.0

12.0

—

(3003694) ABO and Rh group [Type] in Blood

856

6887

1.34

11.21

1.6

1.5

—

(3004775) Volume in Urine collected for unspecified duration

178

2.90

11.12

2.7

2.4

690.82

626.86

0.39

124

(3002523) Influenza virus A Ag [Presence] in Specimen

447

2.16

11.03

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

207

2.74

10.99

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

370

2.28

10.98

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

179

1048

1.75

10.92

5.3

3.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

123

640

1.96

10.90

1.4

1.3

—

(3035880) pH of Pleural fluid

3.57

10.74

1.3

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

449

2.13

10.52

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.71

10.41

3.0

2.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

220

2.62

10.31

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.29

10.30

2.7

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

475

3517

1.42

10.28

1.3

1.2

21.24

10.99

u/ml

1.29

168

1413

(3033705) Calcium.ionized [Moles/volume] in Venous blood

245

2.52

10.18

3.6

2.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

118

620

1.94

10.18

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

2763

26566

1.70

10.14

44.1

18.7

250.18

248.92

e9/l

0.40

2717

25910

(3010813) Leukocytes [#/volume] in Blood

2765

26594

1.71

10.08

44.1

18.7

7.39

6.69

e9/l

12.99

2714

25867

(40768795) Lymph node Pathology biopsy report

200

2.68

10.03

1.5

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

104

3.39

9.99

1.3

1.7

—

(3035941) MCH [Entitic mass]

2764

26588

1.70

9.99

43.9

18.6

30.13

30.28

3.73

2752

26236

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

736

5873

1.34

9.99

2.0

1.6

1.66

1.40

mmol/l

7.75

641

4974

(3009542) Hematocrit [Volume Fraction] of Blood

2761

26552

1.69

9.99

47.6

18.8

39.40

40.99

7.40

2677

24944

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

497

3727

1.40

9.98

1.4

1.2

43.37

29.49

iu/ml

1.30

159

1185

(3024731) MCV [Entitic volume]

2764

26590

1.70

9.96

43.9

18.6

90.85

90.60

1.89

2752

26241

(3048689) Calprotectin [Mass/mass] in Stool

405

2930

1.44

9.94

2.7

2.5

163.60

131.54

ug/g

0.89

328

2338

(3026361) Erythrocytes [#/volume] in Blood

2764

26593

1.69

9.92

44.1

18.7

4.44

4.56

e12/l

22.78

2714

25875

(3020876) Protein [Mass/time] in 24 hour Urine

237

2.52

9.86

3.6

2.7

1.60

1.81

g/24h

0.19

128

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

469

2.06

9.77

1.8

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

2764

26604

1.69

9.76

44.5

18.8

132.08

137.25

g/l

51.07

2752

26245

(3003338) MCHC [Mass/volume]

2227

20631

1.33

9.63

36.3

16.1

331.34

333.55

g/l

22.15

2221

20465

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.75

9.59

1.2

99.40

89.24

0.71

(40757373) Influenza virus identified in Isolate

5.03

9.56

2.3

1.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

294

2011

1.51

9.56

3.5

4.2

4.98

17.80

ug/l

2.21

231

1639

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

166

2.80

9.49

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

166

2.80

9.49

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

166

2.80

9.49

1.2

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

414

2.11

9.47

2.4

2.0

—

4.57

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

105

544

1.96

9.46

1.5

31.17

32.59

e6/l

0.02

423

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

105

544

1.96

9.46

1.6

858.59

1193.59

e6/l

0.21

438

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

665

5272

1.34

9.35

1.3

1.19

1.60

u/ml

0.66

164

1390

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

123

675

1.86

9.33

2.0

1.8

—

(3016750) Collection duration of Urine

141

2.93

9.23

2.9

2.3

486.85

497.25

min

0.19

107

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

169

2.75

9.19

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

508

1.98

9.18

6.3

4.2

—

(3047189) Immunofixation for 24 hour Urine

100

3.33

9.16

1.8

—

(3000060) B lymphocytes [#/volume] in Blood

3.66

8.99

1.8

1.9

188.00

292.22

e6/l

0.54

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

114

619

1.88

8.95

1.5

1.4

814.11

525.01

mg/l

0.63

106

587

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.45

8.92

14.3

7.1

4.76

6.62

mmol/l

1.86

(3007566) Smooth muscle Ab [Titer] in Serum

116

636

1.86

8.84

1.2

1.3

121.11

78.55

titre

—

(40762365) Oxygen content in Arterial blood by calculation

4.90

8.83

1.9

2.9

15.45

15.46

ml/dl

0.00

(1002224) Polysomnography panel

168

1031

1.67

8.68

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

169

2.69

8.64

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

169

2.69

8.64

1.2

1.1

—

(3034426) Prothrombin time (PT)

3.52

8.51

1.5

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.69

8.44

2.7

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.69

8.44

2.7

2.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.48

8.36

1.1

1.0

95.64

88.16

0.66

(3003327) Ova and parasites identified in Stool by Light microscopy

134

781

1.75

8.36

1.9

1.7

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

3.63

8.28

1.5

1.4

63.10

59.56

0.15

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

271

2.28

8.23

2.1

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

204

1332

1.57

8.20

3.8

3.4

4.32

4.54

pmol/l

2.41

183

1182

(3044290) Cell count panel - Cerebral spinal fluid

508

1.92

8.18

1.4

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.58

8.12

3.1

2.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

147

2.74

8.02

2.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

346

2.11

8.02

2.1

1.3

65.68

66.23

mmol/l

0.03

279

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

268

2.26

8.00

2.1

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

264

2.26

7.84

1.3

1.2

46.72

62.02

u/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

517

1.89

7.77

3.1

2.4

186.45

116.76

ug/min

0.59

327

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

111

3.00

7.77

1.8

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

440

1.96

7.74

1.3

1.2

1.35

4.23

u/ml

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

15.05

7.71

1.2

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

100

548

1.85

7.68

1.3

1.2

2.87

2.58

u/ml

—

(3022145) Colonoscopy Study observation

333

2445

1.41

7.47

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

270

2.21

7.45

2.1

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

270

2.21

7.45

1.8

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

496

1.88

7.44

5.0

2.0

0.96

0.83

nmol/l

0.98

419

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

100

554

1.83

7.43

1.3

1.2

6.39

6.40

u/ml

0.00

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.55

7.41

1.5

1.2

—

(3022621) pH of Urine by Test strip

214

1445

1.52

7.41

3.4

2.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

114

658

1.76

7.39

2.3

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

110

2.93

7.27

1.8

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2350

22178

1.30

7.27

5.1

4.2

6.12

5.90

mmol/l

9.55

2220

20325

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1011

8695

1.25

7.21

5.8

3.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

370

2.00

7.09

3.4

3.1

0.86

0.82

nmol/l

0.21

286

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.46

6.90

1.8

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

563

4546

1.30

6.70

1.9

1.7

471.84

35220877.70

pmol/l

4.37

486

3833

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

551

1.79

6.68

1.4

3.99

3.75

mmol/l

1.08

515

(3001893) Eosinophils/100 leukocytes in Pleural fluid

3.46

6.56

1.5

1.4

2.34

2.38

0.01

(3013005) Retinol [Moles/volume] in Serum or Plasma

106

2.85

6.52

3.1

1.7

2.14

1.90

umol/l

0.56

100

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

129

799

1.64

6.50

1.3

129.84

229.53

miu/ml

3.55

357

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

287

2.08

6.43

1.3

0.13

0.35

nmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

254

2.15

6.42

1.3

1.5

—

(3023410) Appearance of Cerebral spinal fluid

248

2.16

6.39

1.3

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.07

6.35

3.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

105

622

1.71

6.27

1.5

1.4

272.75

284.14

ug/g

0.24

353

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

430

1.86

6.26

1.3

1.2

54.69

43.15

u/ml

—

(36660697) Celiac disease serology panel - Serum

259

1883

1.41

6.15

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

260

2.10

6.07

1.4

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

195

2.28

6.06

3.7

2.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

8.60

6.05

2.8

3.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

127

800

1.61

6.01

1.3

1.2

1.69

0.80

u/ml

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

268

2.07

6.00

2.1

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.88

5.98

1.6

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.88

5.98

1.6

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.88

5.98

1.6

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.69

5.92

1.1

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

270

2.06

5.89

2.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.91

5.88

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.91

5.88

1.7

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.03

5.83

1.6

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

271

2.05

5.83

2.1

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

712

6008

1.24

5.79

6.4

3.7

0.00

estimate

1.28

345

2063

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.58

5.68

2.5

1.6

190.07

130.86

ng/l

0.40

(3002621) Streptococcal DNAse B [Units/volume] in Serum

7.53

5.63

1.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

536

1.72

5.58

3.0

2.9

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.49

5.55

5.3

3.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

5.38

5.53

1.5

1.7

14.88

7.38

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.86

5.52

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

199

2.18

5.38

4.5

3.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

373

1.84

5.31

5.9

5.4

385.64

372.66

umol/l

0.31

323

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

397

1.81

5.22

1.2

1.1

17.63

115.92

iu/ml

2.25

108

(3044242) Glucose [Moles/volume] in Arterial blood

114

2.56

5.21

2.0

2.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

145

2.36

5.15

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

145

2.36

5.15

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

377

1.82

5.15

1.7

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

250

2.02

5.14

1.3

—

nmol/l

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

327

1.88

5.13

1.1

1.55

1.50

g/l

0.30

300

(3051651) Icteric interference index of Serum or Plasma

127

2.46

5.12

5.1

3.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.86

5.11

1.7

2.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2312

22027

1.24

5.08

4.5

3.7

1.47

1.31

mmol/l

15.45

2177

20376

(3013139) Helicobacter pylori Ag [Presence] in Stool

203

1465

1.41

5.06

1.3

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.36

5.06

3.4

3.1

—

(3017732) Neutrophils [#/volume] in Blood

213

1551

1.40

5.05

4.0

2.9

4.41

5.62

e9/l

1.38

167

1289

(3048879) Bone marrow aspiration report

3.18

5.04

2.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.41

5.02

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

2.42

4.96

1.1

—

(3037121) Protein [Mass/volume] in Urine

122

800

1.55

4.93

4.0

3.3

0.69

0.29

g/l

0.73

363

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

6.02

4.91

1.7

1.3

0.95

2.55

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

6.02

4.91

1.7

1.3

3.92

4.67

mg/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

560

1.65

4.79

1.6

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.49

4.77

2.4

2.8

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.73

4.75

1.7

1.3

6.25

1.58

mg/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

344

1.82

4.71

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

140

2.30

4.61

1.4

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.20

4.56

5.3

5.1

532.00

428.73

umol/l

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.73

4.51

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

113

744

1.54

4.51

3.2

3.5

11.79

5592.32

u/ml

0.88

638

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

174

2.14

4.50

14.8

14.1

942.08

834.70

nmol/l

0.55

166

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

2.41

4.47

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

105

2.49

4.46

2.1

3.2

99.79

128.69

umol/l

0.38

(3008295) Osmolality of Serum or Plasma

243

1.95

4.44

1.2

1.4

280.78

282.66

mosm/kgh2o

0.17

185

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

125

844

1.50

4.44

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

202

2.04

4.43

1.1

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

156

2.19

4.40

2.5

2.0

—

(40768441) Liver Pathology biopsy report

163

2.16

4.37

1.6

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.52

4.35

2.8

4.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.52

4.35

2.8

4.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

346

1.78

4.34

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.35

4.32

1.7

1.4

531.02

25.17

g/l

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

233

1.95

4.25

1.6

59.03

61.41

0.15

152

(3011288) Drugs identified in Urine by Screen method

127

869

1.48

4.25

3.4

2.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.05

4.24

2.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.94

4.16

1.2

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

357

2888

1.27

4.13

1.9

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

154

2.16

4.11

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

4.01

4.09

3.4

3.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

507

1.61

4.04

2.0

1.7

18779.53

14814.61

e6/l

0.14

366

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.02

4.01

11.0

9.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.94

4.00

1.9

1.6

11.53

12.69

g/l

0.15

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

156

2.13

3.99

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

226

1.92

3.92

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

4.08

3.90

1.9

1.4

—

(40768443) Skin Pathology biopsy report

131

921

1.44

3.84

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.43

3.80

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

140

1000

1.42

3.77

2.4

2.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

12.02

3.76

1.8

9.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

509

1.59

3.76

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

273

1.81

3.75

1.4

80.96

50.83

mu/l

0.41

239

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.60

3.74

1.5

1.1

—

(3045414) Leukocytes [Presence] in Urine

136

973

1.42

3.64

2.5

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

123

2.21

3.60

1.3

130.26

138.37

nmol/l

0.45

123

(3014051) Protein [Presence] in Urine by Test strip

564

1.54

3.56

3.1

2.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

124

2.19

3.54

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

100

2.31

3.43

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.56

3.42

1.3

1.2

19.80

23.33

u/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.40

3.39

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.10

3.37

1.1

—

225.20

titre

—

(4034850) Laboratory test

706

0.56

3.37

20.6

8.8

—

(3019225) pH of Specimen

261

2086

1.28

3.36

9.1

4.1

—

(3049717) Cytology report of Urine Cyto stain

115

812

1.43

3.34

2.3

2.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

375

1.64

3.33

2.0

1.8

5.21

5.02

mmol/24h

0.15

327

(3033799) Differential panel - Peritoneal fluid

2.72

3.32

3.6

2.1

—

(3044941) Cell count panel - Synovial fluid

347

1.66

3.24

1.8

1.4

—

(3026480) Teichoate Ab [Titer] in Serum

4.75

3.23

1.0

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2413

23343

1.19

3.23

5.2

4.5

2.70

2.77

mmol/l

3.62

2262

21702

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

212

2677

0.78

3.17

10.5

6.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

117

2.15

3.16

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

146

1089

1.36

3.10

2.2

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

132

2.06

3.06

1.6

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

7.51

3.05

2.0

1.4

65.33

32.63

umol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

7.51

3.05

2.3

1.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

5.01

3.05

1.4

2.3

4.40

3.99

mg/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

106

2.18

3.02

1.1

1.6

1.44

2.04

u/field

0.37

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

100

2.21

2.99

1.1

104.18

93.37

0.54

(3029075) Extractable nuclear Ab panel - Serum

2.47

2.95

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

508

1.51

2.95

1.3

1.2

—

(3025130) Human papilloma virus identified in Specimen

257

1.72

2.94

2.0

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

132

980

1.36

2.90

1.4

20.28

23.53

iu/l

0.57

103

814

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.38

2.89

1.7

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.44

2.87

1.2

1.1

5.40

21.29

—

(3013862) HLA-DP [Type]

6.68

2.87

1.0

—

(40760409) HLA-A [Type] by High resolution

6.68

2.87

1.0

—

(40763590) HLA-DQ beta [Type]

6.68

2.87

1.0

—

(40760410) HLA-B [Type] by High resolution

6.68

2.87

1.0

—

(46236302) HLA-C [Type] by High resolution typing

6.68

2.87

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

3.17

2.85

1.1

—

(3016879) Cocaine [Presence] in Urine

156

1193

1.32

2.83

2.5

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

186

1.84

2.83

1.7

1.5

32.39

29.65

0.15

118

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.34

2.81

1.5

1.2

8.00

47.57

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.09

2.77

1.2

1.1

—

(3047185) IgG [Mass/volume] in Urine

8.34

2.75

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.32

2.74

2.2

2.8

22.60

29.80

umol/l

—

(40765096) Chromosome analysis panel by Banding

2.37

2.72

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

132

1.98

2.70

1.2

1.1

1.13

1.05

ratio

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

6.01

2.70

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

119

2.03

2.66

1.1

1499.29

1507.84

miu/ml

0.01

119

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

658

0.60

2.65

1.3

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

183

1.81

2.65

1.6

1.9

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.80

2.64

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.80

2.64

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.80

2.64

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.80

2.64

2.3

2.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.80

2.64

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

290

1.63

2.60

1.5

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.61

2.57

3.1

2.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.19

2.57

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.01

2.56

1.0

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.46

2.54

2.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.47

2.48

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

163

1281

1.29

2.46

2.4

2.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.82

2.46

2.3

4.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.24

2.44

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

212

1.71

2.39

2.2

2.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

205

1.72

2.37

2.5

1.5

1.49

1.21

promille

0.43

164

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

377

3252

1.18

2.37

2.1

1.8

1.48

1.44

0.39

332

2910

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

2.35

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

460

1.47

2.35

1.1

8.11

6.18

u/ml

0.31

250

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2365

22987

1.15

2.33

4.7

4.1

4.53

4.64

mmol/l

5.72

2219

21505

(3025018) Bordetella pertussis Ab [Titer] in Serum

133

1.89

2.31

1.2

—

(3028300) Cannabinoids [Presence] in Urine

163

1293

1.28

2.31

2.4

2.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.22

2.30

1.9

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

207

1.70

2.30

1.1

—

(3020491) Glucose [Moles/volume] in Blood

170

1.77

2.28

1.6

2.2

9.14

6.63

mmol/l

1.11

116

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.46

2.27

1.4

1.2

—

(3039000) Anion gap in Blood

480

1.45

2.27

14.5

7.4

12.44

11.32

mmol/l

1.36

434

(3011897) Casein IgE Ab [Units/volume] in Serum

2.76

2.27

1.4

0.21

0.89

u/ml

0.80

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.62

2.27

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

127

1.90

2.26

1.7

1.4

0.94

1.25

nmol/l

0.63

101

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

514

1.43

2.26

1.2

1.1

2.52

2.60

u/ml

0.03

267

(3018572) Chloride [Moles/volume] in Blood

481

1.44

2.25

14.5

7.4

102.77

105.58

mmol/l

4.22

435

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

126

1621

0.77

2.25

1.6

1.4

—

(3027008) Opiates [Presence] in Urine

162

1289

1.27

2.24

2.4

2.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.56

2.21

2.0

2.2

—

(3027944) Amphetamines [Presence] in Urine

159

1266

1.27

2.20

2.4

2.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

173

1392

1.26

2.19

1.3

37.26

54.43

au/ml

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

125

965

1.31

2.19

1.8

1.6

342.38

288.36

mu/l

0.92

114

879

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.51

2.18

1.5

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.34

2.18

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

158

1.78

2.17

1.3

1.1

—

3.78

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

569

1.40

2.16

2.1

1.9

4.17

5.04

iu/l

0.30

206

(3010726) Horse dander IgE Ab [Units/volume] in Serum

436

1.45

2.15

1.1

3.17

1.82

u/ml

0.37

222

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.01

2.14

1.2

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

159

1.77

2.13

1.9

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

665

1.36

2.12

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

251

1.60

2.12

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

388

1.48

2.11

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

446

1.44

2.11

1.1

1.62

1.63

u/ml

0.01

189

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

223

2666

0.82

2.10

4.6

4.2

32.48

31.72

0.42

166

1859

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

160

1.76

2.09

1.9

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.01

2.07

1.0

—

(40761535) Cells panel - Urine sediment

212

1762

1.22

2.02

4.5

3.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

335

1.50

2.01

1.1

13.81

4.77

u/ml

0.95

139

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.82

2.00

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.03

1.95

1.1

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.55

1.94

2.0

1.2

0.60

1.00

—

(3042517) Benzodiazepines panel - Urine

2.97

1.93

2.4

—

(3051101) Glucose [Moles/volume] in Cord blood

2.73

1.93

3.0

6.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

186

1534

1.23

1.92

2.3

2.4

11.45

22.90

au/ml

—

128

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

660

1.34

1.92

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

166

1.69

1.87

3.1

2.2

—

(3038026) Centromere Ab [Units/volume] in Serum

174

1.67

1.86

1.3

1.1

—

65.13

—

(42529406) Shigella sp [Presence] in Stool by Culture

673

1.33

1.85

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.17

1.82

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2341

22835

1.13

1.82

4.7

4.1

1.35

1.42

mmol/l

14.30

2189

21241

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

183

1.65

1.81

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

130

1.78

1.81

1.3

1.4

24.80

20.55

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

319

1.48

1.81

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

222

1876

1.20

1.81

2.1

2.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

153

1.71

1.79

1.1

0.52

1.47

u/ml

0.91

(3015076) Soybean IgE Ab [Units/volume] in Serum

138

1.75

1.79

1.1

1.0

1.93

2.70

u/ml

0.11

(3006442) Creatine [Moles/volume] in Serum or Plasma

169

1.66

1.77

1.8

1.4

86.71

82.41

umol/l

0.21

169

(3017446) Testosterone [Moles/volume] in Serum or Plasma

258

2215

1.18

1.76

2.5

2.2

11.42

13.21

nmol/l

3.30

232

2013

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.09

1.76

1.3

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.09

1.76

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

490

1.38

1.74

6.8

3.2

39.18

26.67

mg/l

1.39

309

(3023383) Lactate [Moles/volume] in Pleural fluid

2.23

1.74

1.4

2.91

3.20

mmol/l

0.16

(3036180) Methadone [Presence] in Urine

147

1.71

1.73

2.4

1.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

217

1.57

1.73

2.4

2.1

16.39

20.14

nmol/l

1.27

203

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.67

1.72

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.96

1.69

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

188

1.60

1.66

1.3

1.5

—

(3014891) Appearance of Pleural fluid

2.58

1.66

1.5

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

184

1542

1.21

1.66

1.2

73.85

141.61

iu/ml

3.22

576

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.80

1.65

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.44

1.64

1.4

1.2

—

(4281824) Cell count and differential, peritoneal fluid

181

1.61

1.63

1.3

1.1

—

(3007463) Buprenorphine [Presence] in Urine

3.58

1.61

3.6

5.9

—

(3024263) Appearance of Synovial fluid

113

1.78

1.60

1.6

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.33

1.58

1.1

1.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.00

1.58

1.0

1.1

—

30.29

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

102

806

1.28

1.58

1.5

7.33

7.95

u/l

0.25

654

(3028717) Thiamine [Mass/volume] in Blood

2.70

1.58

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

517

1.34

1.57

1.5

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

423

1.38

1.56

2.6

3.5

62.08

917.69

u/ml

0.82

398

(3004716) Salmonella sp identified in Stool by Organism specific culture

151

1250

1.22

1.55

1.4

1.3

—

(3002619) Bacteria identified in Specimen by Culture

2.28

1.55

1.1

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.34

1.52

2.2

1.2

11.20

16.11

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.34

1.52

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.34

1.52

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

3.34

1.52

1.2

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.34

1.52

1.2

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

207

2410

0.85

1.51

1.9

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

573

1.32

1.50

1.4

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.86

1.50

3.3

9.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.90

1.49

2.6

2.3

245.90

770.91

e6/l

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

2.37

1.45

12.9

11.6

0.32

0.37

umol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

152

1270

1.21

1.44

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.13

1.44

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.13

1.44

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.73

1.43

1.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

880

8263

1.09

1.42

4.2

4.6

2.93

2.73

ug/l

0.08

797

7456

(44813793) Dust mix specific IgE antibody measurement

149

1.62

1.41

1.0

—

(21494755) Public health laboratory ask at order entry panel

233

2669

0.86

1.40

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

149

1249

1.20

1.38

1.4

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

297

2634

1.14

1.37

1.8

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

313

2786

1.14

1.37

1.5

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.61

1.36

2.5

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

332

1.39

1.35

2.3

6.59

7.44

umol/l

0.14

249

(3004616) Nuclear Ab [Presence] in Serum

257

1.45

1.33

1.4

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.92

1.33

1.2

2.1

11760.00

25224.40

e6/l

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.78

1.33

1.6

1.5

1.80

4.20

—

(40758292) HTLV I+II Ab panel - Serum

2.10

1.30

1.6

1.4

—

(3005033) Fetal Nuchal fold Thickness US

570

1.29

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

161

1.56

1.28

1.4

2.0

4.92

1.90

u/field

0.59

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.78

1.28

4.4

2.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.89

1.28

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.09

1.27

2.1

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.29

1.26

1.8

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.40

1.24

1.3

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

2.23

1.24

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

585

1.27

1.20

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

156

1.54

1.20

1.2

1.1

7.96

1.32

u/ml

0.70

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.11

1.18

1.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

704

1.24

1.17

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.15

1.2

3.1

0.40

u/field

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

361

1.34

1.13

1.1

8.20

3.45

u/ml

0.89

175

(3035933) Granulocytes/100 leukocytes in Blood

1.75

1.12

1.1

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.75

1.12

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.34

1.12

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

519

4811

1.10

1.12

2.7

2.9

0.72

0.73

ug/l

0.07

371

3029

(1761868) Lipid panel - Serum or Plasma

914

8678

1.08

1.10

3.3

2.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

702

1.23

1.09

1.3

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.19

1.08

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.19

1.08

1.3

1.1

—

(3044007) Cell count panel - Peritoneal fluid

1.87

1.07

2.9

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

169

1.48

1.07

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

704

1.23

1.06

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

212

1.42

1.03

4.0

4.8

148.16

58.81

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

148

0.54

1.03

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

213

1.41

1.01

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.77

1.00

3.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.00

1.00

1.0

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

702

1.22

0.98

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.18

0.98

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.74

0.96

1.3

7.70

8.73

ug/l

0.43

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

157

1.47

0.96

1.8

1.5

—

(40768793) Breast Pathology biopsy report

410

0.73

0.95

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.72

0.92

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

327

0.70

0.92

1.3

6.08

7.13

mmol/l

1.88

291

(3027035) Albumin [Mass/time] in 24 hour Urine

2.15

0.91

1.3

1.2

—

652.22

—

(3002079) Sodium [Moles/time] in 24 hour Urine

102

1.57

0.90

1.0

1.3

187.00

167.98

mmol/24h

0.35

102

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.00

0.87

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.82

0.85

1.0

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.94

0.84

1.2

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.76

0.83

1.1

1.6

63.97

212.28

nmol/24h

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

327

1.29

0.83

2.0

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

336

1.28

0.83

1.0

1.37

2.22

u/ml

1.38

156

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

129

1.48

0.83

5.4

6.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.88

0.81

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

597

0.80

0.79

1.8

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

268

1.31

0.79

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.82

0.79

1.8

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.82

0.79

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

768

1.18

0.78

1.4

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

165

1.40

0.77

1.6

—

(3017704) Immunofixation for Urine

123

1.47

0.77

2.1

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

198

0.66

0.76

1.7

2.9

15.23

34.05

mg/l

—

150

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.64

0.75

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.09

0.74

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.09

0.74

1.2

1.0

—

(3008607) Semen analysis panel

2.09

0.74

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

597

1.19

0.74

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.64

0.73

1.7

1.2

28.56

29.95

—

(3044009) aPTT.lupus sensitive (LA screen)

2.00

0.72

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

676

0.83

0.72

1.7

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.58

0.71

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

520

0.80

0.69

1.3

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

374

3501

1.08

0.69

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

204

1.33

0.69

1.9

1.3

98909.73

103917.08

e6/l

0.03

142

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.63

0.66

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.79

0.66

1.6

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

167

1510

1.11

0.66

2.0

1.9

—

(3006462) Nitrate [Presence] in Urine

1.48

0.64

2.9

2.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.73

0.64

1.0

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

112

1.43

0.63

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

104

0.58

0.62

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.59

0.61

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.59

0.61

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.67

0.61

1.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.60

0.61

1.4

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

317

1.23

0.59

1.1

1.12

0.33

u/ml

0.35

(37021550) Renin [Units/volume] in Plasma --upright

1.54

0.59

1.5

1.3

46.42

64.79

mu/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.45

0.59

2.3

2.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

114

0.61

0.58

3.7

5.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

114

0.61

0.58

1.9

3.0

—

(3000285) Sodium [Moles/volume] in Blood

1.72

0.57

1.3

1.0

—

(3022689) Creatine [Moles/volume] in Urine

1.48

0.57

1.9

1.4

—

(4146454) Self-monitoring of blood glucose

229

1.27

0.56

3.3

2.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.46

0.56

1.5

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

117

1051

1.12

0.55

3.0

2.4

5455.09

6098.91

u/l

0.08

417

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

340

1.21

0.53

1.7

1.5

0.33

0.34

nmol/l

0.05

279

(3039443) Prostate specific Ag panel - Serum or Plasma

566

0.85

0.52

1.5

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

336

3174

1.07

0.51

2.1

—

(3006270) Folate [Moles/volume] in Blood

171

1.29

0.49

1.0

1.1

369.75

392.77

nmol/l

0.20

153

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.49

0.47

8.0

1.9

1.23

1.20

mmol/l

—

(3045424) Erythrocytes [Presence] in Urine

376

1.17

0.44

1.9

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

211

1.23

0.43

1.1

41.81

42.35

mg/l

0.03

173

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.61

0.43

1.6

2.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.61

0.43

1.0

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

173

0.75

0.42

1.8

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.52

0.41

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

337

3222

1.05

0.37

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

907

1.09

0.36

2.9

29.38

57.43

u/ml

2.34

874

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

254

1.18

0.35

2.0

2.1

42.75

21.32

mg/l

—

(3019150) Specific gravity of Urine by Refractometry

508

4916

1.04

0.34

5.3

3.6

1.02

kg/l

0.42

712

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

643

1.11

0.34

1.1

6.80

4.51

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

676

6601

1.03

0.29

3.5

4.0

22.86

21.65

0.98

304

2996

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

158

1.20

0.28

2.5

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.18

0.24

2.3

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

152

1.19

0.23

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.22

0.22

1.8

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

116

1.21

0.22

1.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

7.6

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.17

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.91

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.16

0.21

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.15

0.19

1.2

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

941

1.05

0.18

1.7

6.60

4.43

mg/l

0.61

670

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

308

0.91

0.16

1.6

1.5

—

(3020650) Glucose [Presence] in Urine

1.11

0.16

1.4

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.76

0.15

1.5

1.8

—

(3008898) HLA-B27 [Presence]

861

0.95

0.15

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

478

1.07

0.15

2.2

1.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

333

1.08

0.14

1.2

—

(40768800) Prostate Pathology biopsy report

470

0.94

0.14

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

122

1.15

0.13

1.0

1.5

—

(3015183) Erythrocyte sedimentation rate

142

1.13

0.12

1.1

1.2

—

(3005570) Glucose [Moles/volume] in Urine

221

1.09

0.11

2.1

2.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

138

1342

1.03

0.11

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

888

1.04

0.10

1.2

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

202

1.09

0.10

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.15

0.10

1.1

—

(3014271) Vancomycin [Susceptibility]

1.15

0.10

2.2

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.09

0.09

1.8

3.0

—

(3051593) INR in Capillary blood by Coagulation assay

1.15

0.09

13.1

12.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

155

0.90

0.09

1.1

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.03

0.08

20.8

7.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

255

0.94

0.07

1.3

1.4

150.89

207.85

pmol/l

0.79

255

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

163

0.92

0.07

1.0

1.1

0.90

1.09

u/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.11

0.05

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

997

0.98

0.04

2.5

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

663

1.00

0.00

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

163

0.98

0.00

1.0

1.4

1.44

1.53

g/l

0.98

163

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

2.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

-0.00

0.0

2.2

—

1072.33

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

30.33

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.85

-0.00

1.4

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint VIRALPNEUMONAS and mortality.

Females

Parameter	HR [95% CI]	p-value
VIRALPNEUMONAS	2.255 [1.88, 2.71]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.902

During the follow-up period (1.1.1998 — 31.12.2019), 827 out of 3529 females with VIRALPNEUMONAS died.

Males

Parameter	HR [95% CI]	p-value
VIRALPNEUMONAS	2.692 [2.21, 3.28]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.023

During the follow-up period (1.1.1998 — 31.12.2019), 901 out of 3975 males with VIRALPNEUMONAS died.

Mortality risk

Mortality risk for people of age

years, who have VIRALPNEUMONAS.

N-year risk	Females	Males
1	0.203%	0.548%
5	1.273%	3.523%
10	3.244%	8.66%
15	6.991%	15.832%
20	12.016%	25.6%

Relationships between endpoints

↥

Index endpoint: VIRALPNEUMONAS – Viral pneumonia (unknown virus, not influenza)

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Viral pneumonia (unknown virus, not influenza)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints